<SEC-DOCUMENT>0001326190-25-000066.txt : 20251106
<SEC-HEADER>0001326190-25-000066.hdr.sgml : 20251106
<ACCEPTANCE-DATETIME>20251106162538
ACCESSION NUMBER:		0001326190-25-000066
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20251106
DATE AS OF CHANGE:		20251106

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Altimmune, Inc.
		CENTRAL INDEX KEY:			0001326190
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				202726770
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-285355
		FILM NUMBER:		251458791

	BUSINESS ADDRESS:	
		STREET 1:		910 CLOPPER ROAD
		STREET 2:		SUITE 201S
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878
		BUSINESS PHONE:		2406541450

	MAIL ADDRESS:	
		STREET 1:		910 CLOPPER ROAD
		STREET 2:		SUITE 201S
		CITY:			GAITHERSBURG
		STATE:			MD
		ZIP:			20878

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHARMATHENE, INC
		DATE OF NAME CHANGE:	20071016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHCARE ACQUISITION CORP
		DATE OF NAME CHANGE:	20050505
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>alt-20251106x424b5.htm
<DESCRIPTION>424B5
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge  11.1.0.82--><!--Created on: 11/6/2025 09:20:19 PM (UTC)--><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Filed Pursuant to Rule 424(b)(5)</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Registration No. 333-285355</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">PROSPECTUS SUPPLEMENT</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(To Prospectus dated March 13, 2025)</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';"><img src="alt-20251106x424b5001.jpg" alt="Graphic" style="display:inline-block;height:80.28pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:125.25pt;"></font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Up to $200,000,000</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;padding-bottom:1pt;text-align:center;border-bottom:1px solid #000000;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Common Stock</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We have entered into an equity distribution agreement, dated November 6, 2025, or the Equity Distribution Agreement, with Leerink Partners LLC, or the sales agent, relating to shares of our common stock, par value $0.0001 per share, offered by this prospectus supplement. In accordance with the terms of the Equity Distribution Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $200.0 million from time to time through the sales agent,</font> <font style="font-family:'Times New Roman','Times','serif';">pursuant to this prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our common stock is currently listed on The Nasdaq Global Market under the symbol &#8220;ALT.&#8221; On November 5, 2025, the last reported sale price of our common stock was $3.75 per share.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Sales of our common stock, if any, under this prospectus supplement will be made in sales deemed to be &#8220;at the market offerings&#8221; as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended, or the Securities Act. The sales agent is not required to sell any specific amount of securities, but will act as our sales agent using commercially reasonable efforts consistent with their normal trading and sales practices, on mutually agreed terms between the sales agent and us. There is no arrangement for funds to be received in any escrow, trust or similar arrangement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The sales agent will be entitled to compensation at a commission rate of up to 3.0% of the aggregate gross sales sold thereunder. In connection with its sale of common stock on our behalf, the sales agent will be deemed to be an &#8220;underwriter&#8221; within the meaning of the Securities Act, and the compensation of the sales agent will be deemed to be underwriting commissions or discounts.</font></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="0.75" width="25.0%" style="background-color:#000000;color:#000000;height:1px;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Investing in our common stock involves a high degree of risk. You should review carefully the risks and uncertainties described under the heading &#8220;</b><a style="font-family:'Times New Roman','Times','serif';" href="#RISKFACTORS_856197"><b style="font-style:normal;font-weight:bold;">Risk Factors</b></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#8221; on page&#160;S-</b><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;">5</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"> of this prospectus supplement, and under similar headings in the documents that are incorporated by reference into this prospectus supplement and the accompanying prospectus.</b></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="0.75" width="25.0%" style="background-color:#000000;color:#000000;height:1px;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities, or passed upon the adequacy or accuracy of this prospectus supplement and the accompanying prospectus. Any representation to the contrary is a criminal offense.</b></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:12pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="0.75" width="25.0%" style="background-color:#000000;color:#000000;height:1px;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:16pt;font-weight:bold;">Leerink Partners</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The date of this prospectus supplement is November 6, 2025.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><a name="TOC"></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">TABLE OF CONTENTS</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PROSPECTUS SUPPLEMENT</b></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#ABOUTTHISPROSPECTUSSUPPLEMENT_741542"><font style="font-style:normal;font-weight:normal;">ABOUT THIS PROSPECTUS SUPPLEMENT</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">1</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#PROSPECTUSSUPPLEMENTSUMMARY"><font style="font-style:normal;font-weight:normal;">PROSPECTUS SUPPLEMENT SUMMARY</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">3</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#THEOFFERING"><font style="font-style:normal;font-weight:normal;">THE OFFERING</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">4</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#RISKFACTORS_856197"><font style="font-style:normal;font-weight:normal;">RISK FACTORS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">5</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#SPECIALNOTEREGARDINGFORWARDLOOKINGSTATEM"><font style="font-style:normal;font-weight:normal;">SPECIAL STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">7</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#USEOFPROCEEDS_93212"><font style="font-style:normal;font-weight:normal;">USE OF PROCEEDS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">9</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DILUTION_516257"><font style="font-style:normal;font-weight:normal;">DILUTION</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">10</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#Pro_supp_PlanOfDistribution"><font style="font-style:normal;font-weight:normal;">PLAN OF DISTRIBUTION</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">11</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#LEGALMATTERS_744486"><font style="font-style:normal;font-weight:normal;">LEGAL MATTERS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">12</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#EXPERTS_699535"><font style="font-style:normal;font-weight:normal;">EXPERTS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">13</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#WHEREYOUCANFINDMOREINFORMATION_698614"><font style="font-style:normal;font-weight:normal;">WHERE YOU CAN FIND MORE INFORMATION</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">14</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#INCORPORATIONOFDOCUMENTSBYREFERENCE_4377"><font style="font-style:normal;font-weight:normal;">INCORPORATION OF DOCUMENTS BY REFERENCE</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">S-</font><font style="font-family:'Times New Roman','Times','serif';">15</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PROSPECTUS</b></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:6pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#ABOUTTHIS_281017"><font style="font-style:normal;font-weight:normal;">ABOUT THIS PROSPECTUS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">1</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#RISK_755360"><font style="font-style:normal;font-weight:normal;">RISK FACTORS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">2</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#SPECIALNOTEREGARD_338512"><font style="font-style:normal;font-weight:normal;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">3</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#OUR_COMPANY_PROSP"><font style="font-style:normal;font-weight:normal;">OUR COMPANY</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">4</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#USEOF_375312"><font style="font-style:normal;font-weight:normal;">USE OF PROCEEDS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">6</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#SECURITIESWEMAYSELL"><font style="font-style:normal;font-weight:normal;">SECURITIES WE MAY OFFER</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">7</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFCAPITALSTOCK_PROSP"><font style="font-style:normal;font-weight:normal;">DESCRIPTION OF CAPITAL STOCK</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">8</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFDEBTSECURITIES_PROSP"><font style="font-style:normal;font-weight:normal;">DESCRIPTION OF DEBT SECURITIES</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">12</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFWARRANTS_PROSP"><font style="font-style:normal;font-weight:normal;">DESCRIPTION OF WARRANTS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">18</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFUNITS_PROSP"><font style="font-style:normal;font-weight:normal;">DESCRIPTION OF UNITS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">19</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#PLANOFDISTRIBUTION_PROSP"><font style="font-style:normal;font-weight:normal;">PLAN OF DISTRIBUTION</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">22</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#LEGAL_784747"><font style="font-style:normal;font-weight:normal;">LEGAL MATTERS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">25</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#EXP_372498"><font style="font-style:normal;font-weight:normal;">EXPERTS</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">25</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#WHEREYOU_668710"><font style="font-style:normal;font-weight:normal;">WHERE YOU CAN FIND MORE INFORMATION</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">26</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:92.6%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#INCORPORATI_88026"><font style="font-style:normal;font-weight:normal;">INCORPORATION BY REFERENCE</font></a></p></td><td style="vertical-align:bottom;width:7.39%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">27</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td colspan="2" style="vertical-align:bottom;width:100%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-i</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">ABOUT THIS PROSPECTUS SUPPLEMENT</b><a name="ABOUTTHISPROSPECTUSSUPPLEMENT_741542"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This document is part of a &#8220;shelf&#8221; registration statement on Form S-3 that we filed with the SEC and is in two parts. The first part, the accompanying prospectus dated February 27, 2025, including the documents incorporated by reference into it, provides more general information. Generally, when we refer to this &#8220;prospectus,&#8221; we are referring to both parts of this document combined. The second part is this prospectus supplement, which describes the specific terms of this offering of shares of common stock and also adds to and updates information contained in the accompanying prospectus and the documents incorporated by reference into this prospectus supplement and the accompanying prospectus.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This prospectus supplement relates only to an offering of up to $200.0 million of shares of our common stock through the sales agent. These sales, if any, will be made pursuant to the terms of the Equity Distribution Agreement, a copy of which is filed as an exhibit to the registration statement of which this prospectus supplement forms a part and is incorporated by reference into this prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Before you invest, you should carefully read this prospectus supplement, the accompanying prospectus, all information incorporated by reference herein and the additional information described under &#8220;Where You Can Find More Information&#8221; and &#8220;Incorporation of Documents by Reference&#8221;. These documents contain information you should consider when making your investment decision. To the extent that any statement that we make in this prospectus supplement is inconsistent with statements made in the accompanying prospectus or in any documents incorporated by reference, the statements made in this prospectus supplement will be deemed to modify or supersede those made in such documents; however, if any statement in one of these documents is inconsistent with a statement in another document having a later date and that is incorporated by reference herein, the statement in the document having the later date modifies or supersedes the earlier statement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">You should rely only on the information contained or incorporated by reference in this prospectus supplement, the accompanying prospectus, the documents incorporated by reference herein and any free writing prospectus we provide you. We have not, and the sales agent is not, authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not, and the sales agent is not, making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus supplement, the accompanying prospectus, the documents incorporated by reference herein and any free writing prospectus we provide you is accurate only as of the date on those respective documents. Our business, financial condition, results of operations and prospects may have changed since those dates. You should read this prospectus supplement, the accompanying prospectus, including the documents incorporated by reference herein, when making your investment decision.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The distribution of this prospectus supplement and the accompanying prospectus and the offering of the common stock in certain jurisdictions may be restricted by law. Persons outside the United States, or the U.S., who come into possession of this prospectus supplement and the accompanying prospectus must inform themselves about, and observe any restrictions relating to, the offering of the common stock and the distribution of this prospectus supplement and the accompanying prospectus outside the U.S. This prospectus supplement and the accompanying prospectus does not constitute, and may not be used in connection with, an offer to sell, or a solicitation of an offer to buy, any securities offered by this prospectus supplement and the accompanying prospectus by any person in any jurisdiction in which it is unlawful for such person to make such an offer or solicitation.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise indicated, information contained in this prospectus supplement, the accompanying prospectus or the documents incorporated by reference herein concerning our industry and the markets in which we operate, including our general expectations and market position, market opportunity and market share, is based on information from our own management estimates and research, as well as from industry and general publications and research, surveys and studies conducted by third parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge, which we believe to be reasonable. In addition, assumptions and estimates of our and our industry&#8217;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#8220;Risk Factors&#8221; in this prospectus supplement, and the accompanying prospectus and in our most recent Annual Report, as filed with the SEC, as amended, supplemented or superseded from time to time by other reports we file with the SEC in the future, which are </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-1</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">incorporated by reference into this prospectus supplement. These and other important factors could cause our future performance to differ materially from our assumptions and estimates. See &#8220;Special Note Regarding Forward-Looking Statements.&#8221;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;Altimmune,&#8221; our logo and other trademarks, trade names or service marks of ours appearing in this prospectus supplement are our property. The other trademarks, trade names and service marks appearing in this prospectus supplement are the property of their respective owners. We do not intend our use or display of other companies&#8217; trademarks, trade names or service marks to imply an endorsement or sponsorship of us by such companies, or any relationship with such companies. Solely for convenience, trademarks and trade names referred to in this prospectus supplement may appear without the </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">&#174;</sup><font style="font-family:'Times New Roman','Times','serif';"> or </font><sup style="font-family:'Times New Roman','Times','serif';font-size:7.5pt;vertical-align:top;">TM</sup><font style="font-family:'Times New Roman','Times','serif';"> symbol.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise indicated or the context otherwise requires, all references in this prospectus supplement to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Altimmune,&#8221; the &#8220;Company&#8221; and similar designations refer to Altimmune, Inc., together with its subsidiaries. General information about us can be found on our website at www.altimmune.com. The information contained on, or that can be accessed through, our website is not a part of this prospectus supplement. We have included our website address in this prospectus supplement solely as an inactive textual reference.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="margin-left:4%;margin-right:4%;max-width:100%;padding-left:6.34%;padding-right:6.34%;position:relative;"><div style="min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:24.5pt 4% 0pt 4%;padding:38.85pt 6.34% 38.85pt 6.34%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PROSPECTUS SUPPLEMENT SUMMARY</b><a name="PROSPECTUSSUPPLEMENTSUMMARY"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">This summary highlights certain information about us, this offering and selected information contained elsewhere in or incorporated by reference into this prospectus supplement and the accompanying prospectus. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in our common stock. For a more complete understanding of our company and this offering, we encourage you to read and consider carefully the more detailed information in this prospectus supplement and the accompanying prospectus, including the information incorporated by reference into this prospectus supplement and the accompanying prospectus, and the information referred to under the heading &#8220;</i><a style="font-family:'Times New Roman','Times','serif';" href="#RISKFACTORS_ProSupplement"><i style="font-style:italic;font-weight:normal;">Risk Factors</i></a><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">&#8221; in this prospectus supplement on page S-</i><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">5</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;"> and in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Our Business</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Overview</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Altimmune, Inc. is a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases. Our lead program is pemvidutide (formerly known as ALT-801), a balanced 1:1 glucagon/GLP-1 dual receptor agonist for the treatment of metabolic associated steatohepatitis (&#8220;MASH&#8221;), alcohol use disorder (&#8220;AUD&#8221;) and alcohol-associated liver disease (&#8220;ALD&#8221;). We may also pursue additional indications for pemvidutide that leverage our differentiated clinical profile.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Corporate History</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We were incorporated in Delaware in April 2005 and subsequently changed our name to Altimmune, Inc. in May 2017 upon the completion of our merger with PharmAthene, Inc. Our principal executive offices are located at 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878, and our telephone number is (240) 654-1450. Our Internet website is www.altimmune.com and our investor relations website is located under the &#8220;Investors&#8221; tab. The information contained on, or that can be accessed through, our website is not a part of this prospectus supplement. We have included our website address in this prospectus supplement solely as an inactive textual reference.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:3.92%;margin-right:3.92%;margin-top:30pt;page-break-after:always;width:92.16%;border-width:0;"><div style="margin-left:4%;margin-right:4%;max-width:100%;padding-left:6.34%;padding-right:6.34%;position:relative;"><div style="min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div></div><div style="max-width:100%;position:relative;border-bottom:1px solid #000000;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;margin:24.5pt 4% 0pt 4%;padding:38.85pt 6.34% 38.85pt 6.34%;"><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">THE OFFERING</b><a name="THEOFFERING"></a></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:65.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Common stock offered by us</b></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Shares of our common stock</font> <font style="font-family:'Times New Roman','Times','serif';">having an aggregate offering price of up to $200.0 million.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Common stock outstanding immediately following the offering</b></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:65.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">157,675,718 shares, assuming sales of 53,333,333 shares of our common stock in this offering at an offering price of $3.75 per share, which was the last reported sale price of our common stock on The Nasdaq Global Market on November 5, 2025. The actual number of shares issued will vary depending on how many shares of our common stock we choose to sell and the prices at which such sales occur.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Plan of Distribution</b></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:top;width:65.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;At the market offering&#8221; that may be made from time to time through the sales agent. See &#8220;Plan of Distribution&#8221; on page S-</font><font style="font-family:'Times New Roman','Times','serif';">11</font><font style="font-family:'Times New Roman','Times','serif';"> of this prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Use of Proceeds</b></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:65.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our management will retain broad discretion regarding the allocation and use of the net proceeds. We intend to use the net proceeds from this offering for working capital and general corporate purposes. See &#8220;</font><a style="font-family:'Times New Roman','Times','serif';" href="#USEOFPROCEEDS_93212"><i style="font-style:italic;font-weight:normal;">Use of Proceeds</i></a><font style="font-family:'Times New Roman','Times','serif';">&#8221; for additional information.</font></p></td></tr><tr><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Risk Factors</b></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:65.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Investing in our securities involves risks. See &#8220;</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Risk Factors</i><font style="font-family:'Times New Roman','Times','serif';">&#8221; beginning on page S-5 of this prospectus supplement and other information included or incorporated by reference into this prospectus supplement and the accompanying prospectus for a discussion of the factors you should carefully consider before deciding to invest in our securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:top;width:32.45%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Nasdaq Global Market symbol </b></p></td><td style="vertical-align:top;width:1.84%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:65.7%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#8220;ALT&#8221;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The number of shares of common stock to be outstanding after the offering is based on 95,598,665 shares outstanding as of September 30, 2025 and includes 8,743,720 shares of common stock issued through our at-the-market offering program from September 30, 2025 to November 5, 2025, and excludes:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8,661,357 shares of our common stock issuable upon the exercise of stock options outstanding as of September 30, 2025, at a weighted average exercise price of $8.24 per share;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1,135,950 shares of our common stock issuable upon the vesting of restricted stock units outstanding as of September 30, 2025;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4,301,248 shares reserved for issuance under our 2017 Omnibus Incentive Plan and 2018 Inducement Grant Plan as of September 30, 2025; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60,585 shares reserved for issuance under our 2019 Employee Stock Purchase Plan as of September 30, 2025.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Except as otherwise indicated, all information in this prospectus supplement assumes no exercise of stock options listed above and no issuance of shares available, or that may become available, for future issuance under our equity compensation plans after September 30, 2025.</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:3.92%;margin-right:3.92%;margin-top:30pt;page-break-after:always;width:92.16%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">RISK FACTORS</b><a name="RISKFACTORS_856197"></a><a name="RISKFACTORS_ProSupplement"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Investing in our common stock involves a high degree of risk. Investors should carefully consider the risks described below and under the heading &#8220;Risk Factors&#8221; in our most recent Annual Report on Form 10-K, as well as other information in this prospectus supplement and the documents incorporated by reference herein before deciding whether to invest in our securities. Such risks and uncertainties and those discussed below are not the only ones facing us. Additional risks and uncertainties not presently known to us, or that we currently see as immaterial, may also harm our business. If any of these risks occur, our business, financial condition and operating results could be harmed, the trading price of our common stock could decline and you could lose part or all of your investment</i><font style="font-family:'Times New Roman','Times','serif';">.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Risks Related to This Offering</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">We will have broad discretion in the use of the net proceeds from this offering and may not use them effectively.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We currently intend to use the net proceeds of this offering for working capital and general corporate purposes, which may include capital expenditures, research and development expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments, business combinations and the repayment, refinancing, redemption or repurchase of indebtedness or capital stock, as further described in the section of this prospectus supplement entitled &#8220;Use of Proceeds&#8221;. We will have broad discretion in the application of the net proceeds in the category of other working capital and general corporate purposes and investors will be relying on the judgment of our management regarding the application of the proceeds of this offering</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The precise amount and timing of the application of these proceeds will depend upon a number of factors, such as the timing and progress of our research and development efforts, our funding requirements and the availability and costs of other funds. As of the date of this prospectus supplement, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering. Depending on the outcome of our efforts and other unforeseen events, our plans and priorities may change and we may apply the net proceeds of this offering in different manners than we currently anticipate.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The failure by our management to apply these funds effectively could harm our business, financial condition and results of operations and compromise our ability to pursue our growth strategy. Furthermore, we might not be able to yield a significant return, if any, on our investment of these net proceeds. You will not have the opportunity to influence our decisions on how to use the net proceeds from this offering. Pending their use, we may invest our cash, including the net proceeds from this offering, in short-term, interest bearing instruments or in a manner that does not produce income or that loses value.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">If you purchase our common stock in this offering, you will incur immediate and substantial dilution in the book value of your shares.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The offering price per share in this offering may exceed the net tangible book value per share of our common stock outstanding prior to this offering. Assuming that an aggregate of 53,333,333 shares of our common stock are sold during the term of the Equity Distribution Agreement with the sales agent at a price of $3.75 per share, the last reported sale price of our common stock on The Nasdaq Global Market on November 5, 2025, for aggregate net proceeds of approximately $196.8 million, after deducting commissions and estimated aggregate offering expenses payable by us, you will experience immediate dilution of $1.12 per share, representing the difference between our as adjusted net tangible book value per share as of September 30, 2025 after giving effect to this offering and the assumed offering price. The exercise of outstanding stock options may result in further dilution of your investment. See the section entitled &#8220;Dilution&#8221; below for a more detailed illustration of the dilution you would incur if you participate in this offering.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">The actual number of shares we will issue under the Equity Distribution Agreement with the sales agent, at any one time or in total, is uncertain.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to certain limitations in the Equity Distribution Agreement with the sales agent and compliance with applicable law, we have the discretion to deliver placement notices to the sales agent at any time throughout the term of the Equity Distribution Agreement. The number of shares that are sold by the sales agent after delivering a placement </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">notice will fluctuate based on the market price of the common stock during the sales period and limits we set with the sales agent.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">You may experience future dilution as a result of future equity offerings.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In order to raise additional capital, we may in the future offer additional shares of our common stock or other securities convertible into or exchangeable for our common stock at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional shares of our common stock, or securities convertible or exchangeable into common stock, in future transactions may be higher or lower than the price per share paid by investors in this offering.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">We do not intend to pay dividends in the foreseeable future.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We have never paid cash dividends on our common stock. We currently intend to retain our future earnings, if any, to finance the operation and growth of our business and currently do not plan to pay any cash dividends in the foreseeable future.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">The common stock offered hereby will be sold in &#8220;at the market offerings,&#8221; and investors who buy shares at different times will likely pay different prices.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Investors who purchase shares in this offering at different times will likely pay different prices, and so may experience different outcomes in their investment results. We will have discretion, subject to market demand, to vary the timing, prices, and quantity of shares sold, and there is no minimum or maximum sales price. Investors may experience a decline in the value of their shares as a result of share sales made at prices lower than the prices they paid.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SPECIAL STATEMENT&#160;REGARDING FORWARD-LOOKING STATEMENTS</b><a name="SPECIALNOTEREGARDINGFORWARDLOOKINGSTATEM"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This prospectus supplement and the accompanying prospectus and the documents incorporated by reference into the prospectus supplement and the accompanying prospectus contain &#8220;forward-looking statements&#8221; by us within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, including, without limitation, statements as to expectations, beliefs and strategies regarding the future. These statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These forward-looking statements rely on a number of assumptions concerning future events and include statements relating to:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to develop and commercialize our current and future product candidates;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to expand our pipeline of product candidates and the success of future product candidate advancements, including the success of future clinical trials, and our ability to commercialize our products;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the reliability of the results of the studies relating to human safety and possible adverse effects resulting from the administration of our new product candidates;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to obtain potential regulatory approvals on the timelines anticipated, or at all;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to obtain additional patents or extend existing patents on the timelines anticipated, or at all;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to identify and consummate potential future strategic partnerships or business combinations;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our expectations regarding the potential market size and the size of the patient populations for our product candidates, if approved or commercial use;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our anticipated financial or operational results;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to obtain additional capital resources;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">breaches of data privacy, or disruptions in our information technology systems;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our ability to continue to satisfy the listing requirements of The Nasdaq Global Market; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our use of proceeds from this offering.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Any forward-looking statements should be considered in light of these factors. Words such as &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;forecasts,&#8221; &#8220;potential,&#8221; &#8220;goal,&#8221; &#8220;contemplates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;hopes,&#8221; &#8220;seeks,&#8221; &#8220;estimates,&#8221; &#8220;strategy,&#8221; &#8220;target,&#8221; &#8220;continues,&#8221; &#8220;ongoing,&#8221; &#8220;opportunity,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;guidance,&#8221; &#8220;likely,&#8221; &#8220;usually,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;can,&#8221; &#8220;designed to,&#8221; &#8220;potential,&#8221; &#8220;future,&#8221; &#8220;foreseeable future&#8221; and similar expressions and variations, and negatives of these words, identify forward-looking statements. These forward-looking statements are based on the expectations, estimates, projections, beliefs and assumptions of our management based on information currently available to management, all of which are subject to change. These forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties that could cause actual results to differ materially from the results contemplated by the forward-looking statements. Many of the important factors that will determine these results and values are beyond our ability to control or predict. You are cautioned not to put undue reliance on any forward-looking statements. Except as otherwise required by law, we do not assume any obligation to update any forward-looking statements.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In evaluating an investment in shares of our common stock, you should carefully consider the discussion of risks and uncertainties described under the heading &#8220;</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Risk Factors</i><font style="font-family:'Times New Roman','Times','serif';">&#8221; contained in this prospectus supplement, and under similar headings in other documents including in other filings with the SEC, which may be amended, supplemented or superseded from time to time by other reports we file with the SEC in the future, that are incorporated by reference in this prospectus supplement. You should carefully read this prospectus supplement together with the information incorporated by reference in this prospectus supplement as described under the headings &#8220;</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Where You Can Find More Information</i><font style="font-family:'Times New Roman','Times','serif';">&#8221; and &#8220;</font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Incorporation of Documents by Reference</i><font style="font-family:'Times New Roman','Times','serif';">&#8221; completely and with the understanding that our actual future results may be materially different from what we expect.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by our cautionary statements. The forward-looking statements included or incorporated by reference herein are made only as of the date of this prospectus supplement (or as of the date of any such </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">document incorporated by reference). We do not intend, and undertake no obligation, to update these forward-looking statements, except as required by law.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">USE OF PROCEEDS</b><a name="USEOFPROCEEDS_93212"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may issue and sell our common stock having aggregate sales proceeds of up to $200.0 million from time to time. Because there is no minimum offering amount required as a condition to close this offering, the actual total public offering amount, commissions and proceeds to us, if any, are not determinable at this time. There can be no assurance that we will sell any shares under or fully utilize the Equity Distribution Agreement as a source of financing.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We currently intend to use the net proceeds from this offering for working capital and general corporate purposes, which may include capital expenditures, research and development expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and investments, business combinations and the repayment, refinancing, redemption or repurchase of indebtedness or capital stock.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The precise amount and timing of the application of these proceeds will depend upon a number of factors, such as the timing and progress of our research and development efforts, our funding requirements and the availability and costs of other funds. As of the date of this prospectus supplement, we cannot specify with certainty all of the particular uses for the net proceeds to us from this offering. Accordingly, our management will have broad discretion in the timing and application of these proceeds. Pending application of the net proceeds as described above, we intend to temporarily invest the proceeds in short-term, interest-bearing instruments.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-9</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DILUTION</b><a name="DILUTION_516257"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If you purchase our common stock in this offering, your interest will be diluted to the extent of the difference between the public offering price per share and the net tangible book value per share of our common stock after this offering. We calculate net tangible book value per share by dividing our net tangible assets (tangible assets less total liabilities) by the number of shares of our common stock issued and outstanding as of September 30, 2025.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our net tangible book value as of September 30, 2025 was approximately $184.1 million, or $1.93 per share. After giving effect to our issuance and sale of an aggregate of 8,743,720 shares of common stock for net proceeds of $33.8 million through our at-the-market offerings program from September 30 to November 5, 2025, our adjusted net tangible book value as of September 30, 2025 would have been $217.9 million or $2.09 per share of common stock. </font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">After giving effect to the assumed sale of our common stock during the term of the Equity Distribution Agreement with the sales agent in the aggregate amount of $200.0 million at an assumed offering price of $3.75 per share, the last reported sale price of our common stock on The Nasdaq Global Market on November 5, 2025, and after deducting commissions and estimated aggregate offering expenses payable by us, our adjusted, as adjusted, net tangible book value as of September 30, 2025 would have been approximately $414.7 million, or $2.63 per share of common stock. This represents an immediate increase in the net tangible book value of $0.54 per share to our existing stockholders and an immediate dilution in net tangible book value of $1.12 per share to new investors. The following table illustrates this per share dilution:</font></p><div align="left"><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Assumed public offering price per share </font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 3.75</font></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Adjusted net tangible book value per share as of September 30, 2025</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 2.09</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Increase in adjusted net tangible book value per share attributable to this offering</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.06%;background:#cceeff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 0.54</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">As adjusted net tangible book value per share as of September 30, 2025, after giving effect to this offering</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.06%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 2.63</font></p></td></tr><tr><td style="vertical-align:bottom;width:64.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Dilution per share to new investors purchasing shares in this offering</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.25%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">$</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;border-bottom:3px double #000000;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';white-space:pre-wrap;"> 1.12</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:12pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The number of shares of common stock to be outstanding after the offering is based on 95,598,665 shares outstanding as of September 30, 2025 and includes 8,743,720 shares of common stock issued through our at-the-market offering program from September 30 to November 5, 2025, and exclude the following:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">8,661,357 shares of our common stock issuable upon the exercise of stock options outstanding as of September 30, 2025, at a weighted average exercise price of $8.24 per share;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1,135,950 shares of our common stock issuable upon the vesting of restricted stock units outstanding as of September 30, 2025:</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">4,301,248 shares reserved for issuance under our 2017 Omnibus Incentive Plan and 2018 Inducement Grant Plan as of September 30, 2025; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">60,585 shares reserved for issuance under our 2019 Employee Stock Purchase Plan as of September 30, 2025.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Except as otherwise indicated, all information in this prospectus supplement assumes no exercise of stock options listed above and no issuance of shares available, or that may become available, for future issuance under our equity compensation plans after September 30, 2025.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">To the extent that options outstanding as of September 30, 2025 have been or are exercised, or other shares are issued, investors purchasing shares in this offering could experience further dilution. In addition, we may choose to raise additional capital due to market conditions or strategic considerations, even if we believe we have sufficient funds for our current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible debt securities, the issuance of these securities could result in further dilution to our stockholders.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 9pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-10</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PLAN OF DISTRIBUTION</b><a name="Pro_supp_PlanOfDistribution"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We have entered into an Equity Distribution Agreement with Leerink Partners LLC as our sales agent under which we may offer and sell shares of our common stock from time to time. Pursuant to this prospectus supplement, we may offer and sell shares having an aggregate gross offering price of up to $200.0 million. The sales agent will use commercially reasonable efforts to sell on our behalf all of the shares of our common stock requested to be sold by us, consistent with their normal trading and sales practices, under the terms and subject to the conditions set forth in the Equity Distribution Agreement. We may instruct the sales agent not to sell our common stock if the sales cannot be effected at or above the price designated by us in any instruction. We or the sales agent may suspend the offering of our common stock upon proper notice and subject to other conditions, as further described in the Equity Distribution Agreement. A copy of the Equity Distribution Agreement is filed as an exhibit to the Company&#8217;s Form 8-K filed with the Securities and Exchange Commission on November 6, 2025.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The sales agent may sell our common stock by any method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) promulgated under the Securities Act, including sales made directly on or through The Nasdaq Global Market or on any other existing trading market for our common stock. The sales agent will provide written confirmation to us following the close of trading on The Nasdaq Global Market each day in which our common stock is sold under the Equity Distribution Agreement. Each such confirmation will include the number of shares of our common stock sold on such day, the net proceeds to us and the compensation payable by us to the sales agent in connection with such sales.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will pay the sales agent commissions for their services in acting as the sales agent in the sale of our common stock. The sales agent will be entitled to compensation in an amount of up to 3.0% of the gross sales price of all common stock sold through it as sales agent under the Equity Distribution Agreement. We have also agreed to reimburse the sales agent for the out-of-pocket reasonable fees and disbursements of its legal counsel, in an amount not to exceed $75,000, as well as certain ongoing expenses. We estimate that the total expenses for this offering, excluding compensation payable to the sales agent under the terms of the Equity Distribution Agreement, will be approximately $235,000.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Settlement for sales of our common stock will occur on the first business day following the date on which any such sales are made, or on some other date that is agreed upon by us and the sales agent in connection with a particular transaction, in return for payment of the net proceeds to us. There is no arrangement for funds to be received in an escrow, trust or similar arrangement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will report at least quarterly the number of shares of our common stock sold through the sales agent, under the Equity Distribution Agreement and the net proceeds to us in connection with such sales.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The sales agent and its affiliates have from time to time provided, and may in the future provide, various investment banking, commercial banking, fiduciary and advisory services for us for which they have received, and may in the future receive, customary fees and expenses. The sales agent and its affiliates may from time to time engage in other transactions with and perform services for us in the ordinary course of their business.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In connection with the sale of our common stock on our behalf, the sales agent will be deemed to be an underwriter within the meaning of the Securities Act, and the compensation paid by us to the sales agent will be deemed to be underwriting commissions or discounts. We have agreed to indemnify the sales agent against specified liabilities, including liabilities under the Securities Act, and to contribute to payments that the sales agent may be required to make because of such liabilities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The offering of our common stock pursuant to the Equity Distribution Agreement will terminate upon the termination of the Equity Distribution Agreement. The Equity Distribution Agreement may be terminated by the sales agent or us at any time on the close of business on the date of receipt of written notice, and by the sales agent at any time in certain circumstances, including any suspension or limitation on the trading of our common stock on The Nasdaq Global Market, as further described therein.</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-11</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">LEGAL MATTERS</b><a name="LEGALMATTERS_744486"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The validity of the issuance of the common stock offered by this prospectus supplement will be passed upon for us by Goodwin Procter LLP. Leerink Partners LLC is being represented in connection with this offering by Cooley LLP, New York, New York.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-12</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXPERTS</b><a name="EXPERTS_699535"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The consolidated financial statements of Altimmune,&#160;Inc. appearing in Altimmune, Inc.&#8217;s Annual Report on Form&#160;10-K for the&#160;year ended December&#160;31, 2024, have been audited by Ernst&#160;&amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-13</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">WHERE YOU CAN FIND MORE INFORMATION</b><a name="WHEREYOUCANFINDMOREINFORMATION_698614"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We are a reporting company and file annual, quarterly and current reports, proxy statements and other information with the SEC. We have filed with the SEC a registration statement on Form&#160;S-3 under the Securities Act with respect to the securities being offered under this prospectus supplement and the accompanying prospectus. This prospectus supplement and the accompanying prospectus do not contain all of the information set forth in the registration statement and the exhibits to the registration statement. For further information with respect to us and the securities being offered under this prospectus supplement and the accompanying prospectus, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement. The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including Altimmune,&#160;Inc. The SEC&#8217;s Internet site can be found at </font><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">www.sec.gov</i><font style="font-family:'Times New Roman','Times','serif';">.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-14</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">INCORPORATION OF DOCUMENTS BY REFERENCE</b><a name="INCORPORATIONOFDOCUMENTSBYREFERENCE_4377"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The SEC allows us to &#8220;incorporate by reference&#8221; information into this prospectus supplement, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The documents incorporated by reference into this prospectus supplement contain important information that you should read about us.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The following documents are incorporated by reference into this prospectus supplement:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our Annual Report on Form&#160;10-K for the fiscal&#160;year ended December&#160;31, 2024, filed with the SEC on February&#160;27, 2025 (the &#8220;</font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000015/alt-20241231x10k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">2024 10-K&#8221;</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">)</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Quarterly Reports on Form 10-Q for the quarterly period ended </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000034/alt-20250331x10q.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">March 31, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, filed with the SEC on May 13, 2025;</font><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">for the quarter ended </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000040/alt-20250630x10q.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">June 30, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, filed with the SEC on August 12, 2025 and for the quarter ended </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000064/alt-20250930x10q.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">September 30, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, filed with the SEC on November 6, 2025.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the Company&#8217;s Current Reports on Form 8-K filed with the SEC on</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000003/alt-20250224x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">February 25, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000011/alt-20250224x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">February 27, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000031/alt-20250513x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">May 13, 2025</font></a><font style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-style:normal;font-weight:normal;">,</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000050/alt-20250925x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">September 25, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">, </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000053/alt-20251001x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">October 3, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000055/alt-20251106xex10d1.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">November 6, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the descriptions of our common stock set forth in the registration statement on Form&#160;8-A registering our common stock under Section 12 of the Exchange Act, which was filed as </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000015/alt-20241231xex4d1.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Exhibit 4.1</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to our 2024 10-K, including any amendments or reports filed for purposes of updating such description</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We also incorporate by reference any future filings (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items unless such Form 8-K expressly provides to the contrary) made with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including those made after the date of the initial filing of the registration statement of which this prospectus supplement is a part and prior to effectiveness of such registration statement, until we file a post- effective amendment that indicates the termination of the offering of the securities made by this prospectus supplement and will become a part of this prospectus supplement from the respective dates that such documents are filed with the SEC. Any statement contained herein or in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof or of the related prospectus supplement to the extent that a statement contained herein or in any other subsequently filed document which is also incorporated or deemed to be incorporated herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Documents incorporated by reference are available from us, without charge. You may obtain documents incorporated by reference in this prospectus supplement by requesting them in writing or by telephone at the following address:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Altimmune,&#160;Inc.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">910 Clopper Road, Suite 201S&#160;</font><font style="font-family:'Times New Roman','Times','serif';"><br></font><font style="font-family:'Times New Roman','Times','serif';">Gaithersburg, Maryland 20878</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Attention: Chief Financial Officer</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:18pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">(240) 654-1450</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">S-15</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PROSPECTUS</b><a name="PROSPECTUS"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;"><img src="alt-20251106x424b5005.jpg" alt="Graphic" style="display:inline-block;height:92.25pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:145.5pt;"></b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">$400,000,000</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Common Stock</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Preferred Stock</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Debt Securities</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Warrants</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Units</b></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="0.75" width="25.0%" style="background-color:#000000;color:#000000;height:1px;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may from time to time issue, in one or more series or classes, up to $400,000,000 in aggregate principal amount of our common stock, preferred stock, debt securities, warrants and/or units. We may offer these securities separately or together in units. We will specify in the applicable accompanying prospectus supplement the terms of the securities being offered. We may sell these securities to or through underwriters and also to other purchasers or through agents. We will set forth the names of any underwriters or agents, and any fees, conversions or discount arrangements, in the applicable accompanying prospectus supplement. We may not sell any securities under this prospectus without delivery of the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">You should read this document and any prospectus supplement or amendment carefully before you invest in our securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our common stock is listed on The Nasdaq Global Market under the symbol &#8220;ALT.&#8221; On February 24, 2025, the closing price for our common stock, as reported on The Nasdaq Global Select Market, was $6.11 per share. Our principal executive office is located at 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Investing in our securities involves a high degree of risk. You should review carefully the risks and uncertainties referenced under the heading &#8220;</b><a style="font-family:'Times New Roman','Times','serif';font-size:12pt;" href="#RISK_755360"><b style="font-style:normal;font-weight:bold;">Risk Factors</b></a><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">&#8221; contained in this prospectus beginning on page 2 and any applicable prospectus supplement, and under similar headings in the other documents that are incorporated by reference into this prospectus.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 8pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">The date of this Prospectus is March 13, 2025.</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">TABLE OF CONTENTS</b></p><div><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;" align="center"><tr style="height:1pt;"><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 0pt 12pt;"><font style="font-family:'Times New Roman','Times','serif';margin-left:0pt;visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Page</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#ABOUTTHIS_281017"><font style="font-style:normal;font-weight:normal;">About This Prospectus</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">1</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#RISK_755360"><font style="font-style:normal;font-weight:normal;">Risk Factors</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">2</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#SPECIALNOTEREGARD_338512"><font style="font-style:normal;font-weight:normal;">Cautionary Statement Regarding Forward-Looking Statements</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">3</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#OUR_COMPANY_PROSP"><font style="font-style:normal;font-weight:normal;">Our Company</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">4</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#USEOF_375312"><font style="font-style:normal;font-weight:normal;">Use of Proceeds</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">6</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#SECURITIESWEMAYSELL"><font style="font-style:normal;font-weight:normal;">Securities We May Offer</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">7</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFCAPITALSTOCK_PROSP"><font style="font-style:normal;font-weight:normal;">Description of Capital Stock</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">8</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFDEBTSECURITIES_PROSP"><font style="font-style:normal;font-weight:normal;">Description of Debt Securities</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">12</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFWARRANTS_PROSP"><font style="font-style:normal;font-weight:normal;">Description of Warrants</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">18</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#DESCRIPTIONOFUNITS_PROSP"><font style="font-style:normal;font-weight:normal;">Description of Units</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">19</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#PLANOFDISTRIBUTION_PROSP"><font style="font-style:normal;font-weight:normal;">Plan of Distribution</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">22</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#LEGAL_784747"><font style="font-style:normal;font-weight:normal;">Legal Matters</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">25</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#EXP_372498"><font style="font-style:normal;font-weight:normal;">Experts</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">25</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#WHEREYOU_668710"><font style="font-style:normal;font-weight:normal;">Where You Can Find More Information</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">26</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr><tr><td style="vertical-align:bottom;width:89.57%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><a style="font-family:'Times New Roman','Times','serif';" href="#INCORPORATI_88026"><font style="font-style:normal;font-weight:normal;">Incorporation by Reference</font></a></p></td><td style="vertical-align:bottom;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;&#160;</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.46%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:right;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">27</font></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.53%;margin:0pt;padding:0pt;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">&#160;</font></p></td></tr></table></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">ABOUT THIS PROSPECTUS</b><a name="ABOUTTHIS_281017"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This prospectus is part of a registration statement on Form S-3 that we filed with the Securities and Exchange Commission, or the SEC, utilizing a &#8220;shelf&#8221; registration process. Under the shelf registration, we may offer shares of our common stock and preferred stock, various series of warrants to purchase common stock or preferred stock, debt securities or any combination thereof, from time to time in one or more offerings.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This prospectus provides you with a general description of the securities we may offer. Each time we sell securities, we will provide one or more prospectus supplements that will contain specific information about the terms of the offering. The applicable prospectus supplement may also add, update or change information contained in this prospectus. You should read both this prospectus and any accompanying prospectus supplement together with the additional information described under the heading &#8220;Where You Can Find More Information&#8221; beginning on page 26 of this prospectus.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">You should rely only on the information contained in or incorporated by reference in this prospectus, the accompanying prospectus supplement or in any related free writing prospectus filed by us with the SEC. We have not authorized anyone to provide you with different information. This prospectus and the accompanying prospectus supplement do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the securities described in the accompanying prospectus supplement or an offer to sell or the solicitation of an offer to buy such securities in any circumstances in which such offer or solicitation is unlawful. You should assume that the information appearing in this prospectus, any prospectus supplement, the documents incorporated by reference and any related free writing prospectus is accurate only as of their respective dates. Our business, financial condition, results of operations and prospects may have changed materially since those dates.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless the context otherwise requires, references to &#8220;Altimmune,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us&#8221; and &#8220;our&#8221; refer to Altimmune, Inc., and its wholly owned, consolidated subsidiaries, or either or all of them as the context may require</font><font style="font-family:'Times New Roman','Times','serif';">.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">1</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">RISK FACTORS</b><a name="RISK_755360"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Investing in our securities involves a high degree of risk. You should carefully consider the risks described in the documents incorporated by reference in this prospectus and any prospectus supplement, as well as other information we include or incorporate by reference into this prospectus and any applicable prospectus supplement, before making an investment decision. Our business, financial condition or results of operations could be materially and adversely affected by the materialization of any of these risks. The trading price of our securities could decline due to the materialization of any of these risks, and you may lose all or part of your investment. This prospectus and the documents incorporated herein by reference also contain forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks described in the documents incorporated herein by reference, including (i) our most recent Annual Report on Form 10-K, which is on file with the SEC and is incorporated herein by reference, and (ii) other documents we file with the SEC that are deemed incorporated by reference into this prospectus, including our Quarterly Reports on Form 10-Q.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">2</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><a name="SPECIALNOTEREGARD_338512"></a><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This prospectus, any applicable prospectus supplement, any related free writing prospectus, and the information incorporated by reference herein and therein contain express or implied statements that are based on our management&#8217;s belief and assumptions and on information currently available to our management are considered forward-looking within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements other than statements of historical facts are forward-looking statements, including statements regarding our future results of operations or of our financial position, business strategy, plans and objectives of management for future operations, or state other forward-looking information. In some cases, you can identify these statements by forward-looking words such as &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; or &#8220;would&#8221; or the negative of these words or other similar terms or expressions. We believe that it is important to communicate our future expectations to our investors. However, there may be events in the future that we are not able to accurately predict or control and that may cause our actual results to differ materially from the expectations we describe in our forward-looking statements.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">These forward-looking statements are neither promises nor guarantees of future performance and relate to future events or our future operational or financial performance, and involve known and unknown risks, uncertainties, and other factors, many of which are beyond our control, that may cause our actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by these forward-looking statements, including, without limitation the risk factors and cautionary statements described in other documents that we file from time to time with the SEC, specifically under &#8220;Item 1A. Risk Factors&#8221; and elsewhere in our most recent Annual Report on Form 10-K and the section of any accompanying prospectus supplement entitled &#8220;Risk Factors,&#8221; as may be updated by our subsequent Quarterly Reports on Form 10-Q and other filings we make with the SEC.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Given these uncertainties, you should not place undue reliance on these forward-looking statements. These forward-looking statements speak only as of the date on which the statements were made and are not guarantees of future performance. Except as may be required by applicable law, we do not undertake or intend to update any forward-looking statements after the date of this prospectus or the respective dates of documents incorporated by reference herein that include forward-looking statements.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">3</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">OUR COMPANY</b><a name="ALTIMMUNEINC_198234"></a><a name="THECOMPANY"></a><a name="OUR_COMPANY_PROSP"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 3pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Our Business</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Overview</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Altimmune, Inc. is a clinical stage biopharmaceutical company focused on developing treatments for obesity, metabolic and liver diseases. Our lead product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic associated steatohepatitis (&#8220;MASH&#8221;). We also expect to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">Pemvidutide</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Pemvidutide is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist currently in clinical development for the treatment of obesity and MASH. Activation of the GLP-1 and glucagon receptors is believed to mimic the complementary effects of diet and exercise on weight loss, with GLP-1 suppressing appetite and glucagon increasing energy expenditure. Glucagon is also recognized as having direct effects on hepatic fat metabolism, which is believed to lead to rapid reductions in levels of liver fat and serum lipids.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Pemvidutide mechanism of action: Optimized for obesity and MASH</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="alt-20251106x424b5007.jpg" alt="Graphic" style="display:inline-block;height:259.2pt;left:0%;padding-bottom:0.3pt;position:relative;top:0pt;width:485.3pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Over 500 subjects have received pemvidutide to date in 6 completed clinical trials. In those trials pemvidutide appear safe and demonstrated what we believe to be a favorable safety profile, compelling weight loss, class-leading lean mass preservation, and robust reductions in triglycerides, low density lipoprotein (&#8220;LDL&#8221;), liver fat content, measures of liver inflammation, and blood pressure. Our clinical development has always focused on the comorbidities of obesity and MASH as these often drive the outcomes of these diseases. Based on the clinical data we have accumulated, we believe pemvidutide may be able to address the most common comorbidities associated with both obesity and MASH as shown below.</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">4</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">U.S. prevalence of comorbidities in obesity and MASH</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><img src="alt-20251106x424b5008.jpg" alt="Graphic" style="display:inline-block;height:250pt;left:0%;padding-bottom:0.5pt;position:relative;top:0pt;width:485.3pt;"></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Corporate History</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We were incorporated in Delaware in April 2005 and subsequently changed our name to Altimmune, Inc. in May 2017 upon the completion of our merger with PharmAthene, Inc. Our principal executive offices are located at 910 Clopper Road, Suite 201S, Gaithersburg, Maryland 20878, and our telephone number is (240) 654-1450. Our Internet website is www.altimmune.com and our investor relations website is located under the &#8220;Investors&#8221; tab. The information contained on, or that can be accessed through, our website is not a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">5</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">USE OF PROCEEDS</b><a name="USEOF_375312"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We intend to use the net proceeds from the sale of any securities offered under this prospectus for general corporate purposes unless otherwise indicated in the applicable prospectus supplement. General corporate purposes may include, but are not limited to research and clinical development of current or additional pipeline candidates, working capital, capital expenditures and other general corporate purposes. We may temporarily invest the net proceeds in a variety of capital preservation instruments, including short-term, investment-grade, interest-bearing instruments and U.S. government securities, or may hold such proceeds as cash, until they are used for their stated purpose. We have not determined the amount of net proceeds to be used specifically for such purposes. As a result, management will retain broad discretion over the allocation of net proceeds.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">6</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SECURITIES WE MAY OFFER OR SELL</b><a name="SecuritiesWeMayOffer"></a><a name="SECURITIESWEMAYSELL"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This prospectus contains summary descriptions of the securities we may offer or sell from time to time. These summary descriptions are not meant to be complete descriptions of each security. The particular terms of any security will be described in the applicable prospectus supplement. This prospectus provides you with a general description of the securities we may offer. Each time we sell securities described herein, we will provide prospective investors with a supplement to this prospectus that will contain specific information about the terms of that offering, including the specific amounts, prices and terms of the securities offered.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may sell the securities to or through underwriters, dealers or agents, directly to purchasers or through a combination of any of these methods of sale or as otherwise set forth below under &#8220;Plan of Distribution.&#8221; We, as well as any agents acting on our behalf, reserve the sole right to accept and to reject in whole or in part any proposed purchase of securities. Any prospectus supplement will set forth the names of any underwriters, dealers, agents or other entities involved in the sale of securities described in that prospectus supplement and any applicable fee, commission or discount arrangements with them.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">7</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DESCRIPTION OF CAPITAL STOCK</b><a name="DESCRIPTIONOFCAPITALSTOCK_39358"></a><a name="DESCRIPTIONOFCAPITALSTOCK_PROSP"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><i style="font-family:'Times New Roman','Times','serif';font-style:italic;">The following description of our common stock and preferred stock, together with the additional information we include in any applicable prospectus supplements, summarizes the material terms and provisions of the common stock and preferred stock that we may offer under this prospectus. The following description of our capital stock does not purport to be complete and is subject to, and qualified in its entirety by, our certificate of incorporation and bylaws, which are exhibits to the registration statement of which this prospectus forms a part, and by applicable law. The terms of our common stock and preferred stock may also be affected by Delaware law.</i></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">General</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under our charter, our authorized capital stock consists of two hundred million (200,000,000) shares of common stock, par value $0.0001 per share, and one million (1,000,000) shares of undesignated preferred stock, par value $0.0001 per share.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Common Stock</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under our Amended and Restated Certificate of Incorporation, as amended, to which we refer as our &#8220;charter,&#8221; we are currently authorized to issue 200,000,000 shares of common stock, par value $0.0001 per share. As of February 24, 2025, we had 77,013,658 shares of common stock outstanding.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Holders of our common stock are entitled to one vote for each share of common stock held of record on all matters to be voted on by stockholders, except as otherwise provided by law or in any preferred stock designation. Our bylaws specify that, except as otherwise required by law or our charter, the presence in person or by proxy of holders of a majority of the shares entitled to vote at a meeting of stockholders will be necessary, and will constitute a quorum, for the transaction of business at such meeting. Our bylaws furthermore specify that all elections of directors will be determined by a plurality of the votes and that, except as otherwise provided by law or in the charter or bylaws, any other matter will be determined by the vote of a majority of the shares which are voted with regard to it. Holders of our common stock have no conversion, preemptive or other subscription rights and there are no sinking fund or redemption provisions applicable to the common stock.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">There is no cumulative voting with respect to the election of directors, with the result that the holders of more than 50% of the shares voting for the election of directors can elect all of the directors then up for election. Holders of our common stock are entitled to receive dividends when, as and if declared by our board of directors out of funds legally available therefor. In the event of our liquidation, dissolution or winding up, the holders of common stock are entitled to share in all assets remaining which are available for distribution to them after payment of liabilities and after provision has been made for each class of stock, if any, having preference over the common stock.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our common stock is listed on The Nasdaq Global Select Market under the trading symbol &#8220;ALT&#8221;.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Annual Meeting</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Annual meetings of our stockholders are held on the date designated in accordance with our amended and restated by-laws. Written notice must be mailed to each stockholder entitled to vote not less than ten nor more than 60 days before the date of the meeting. The presence in person or by proxy of the holders of record of a majority of our issued and outstanding shares entitled to vote at such meeting constitutes a quorum for the transaction of business at meetings of the stockholders. Special meetings of the stockholders may be called for any purpose only by the board of directors pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office. Except as may be otherwise provided by applicable law, our certificate of incorporation or our amended and restated by-laws, all elections of directors shall be decided by a plurality, and all other questions shall be decided by a majority, of the votes cast by stockholders entitled to vote thereon at a duly held meeting of stockholders at which a quorum is present.</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">8</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Voting Rights</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Holders of common stock are entitled to one vote for each share held of record on all matters to be voted upon by stockholders and do not have cumulative voting rights.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Dividends</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to the rights, powers and preferences of any outstanding preferred stock that we may designate and issue in the future, and except as provided by law or in our certificate of incorporation, dividends may be declared and paid or set aside for payment on the Common Stock out of legally available assets or funds when and as declared by our board of directors.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Liquidation, Dissolution and Winding Up</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to the rights, powers and preferences of any outstanding preferred stock that we may designate and issue in the future, in the event of our liquidation, dissolution or winding up, our net assets will be distributed pro rata to the holders of Common Stock.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Other Rights</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Holders of Common Stock have no preemptive, subscription, redemption or conversion rights. The rights, preferences and privileges of holders of Common Stock are subject to and may be adversely affected by the rights of the holders of shares of any series of preferred stock that we may designate and issue in the future. Holders of Common Stock are not required to make additional capital contributions.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Transfer Agent</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The transfer agent and registrar for the common stock is Continental Stock Transfer &amp; Trust Company, New York, New York.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Preferred Stock</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under our charter, we are currently authorized to issue 1,000,000 shares of preferred stock, par value $.0001 per share. As of December 31, 2024, we had no shares of preferred stock issued and outstanding.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under our charter, our board of directors is expressly granted authority to issue shares of preferred stock, in one or more series, and to fix for each series such voting powers, full or limited, and such designations, preferences and relative, participating, optional or other special rights and such qualifications, limitations or restrictions as it may determine in the resolution or resolutions providing for the issue of such series (to which we also refer as a &#8220;preferred stock designation&#8221;) and as may be permitted by the Delaware General Corporation Law. The number of authorized shares of preferred stock may be increased or decreased (but not below the number of shares of preferred stock then outstanding) by the affirmative vote of the holders of a majority of the voting power of all of the then outstanding shares of our capital stock entitled to vote generally in the election of directors, voting together as a single class, without a separate vote of the holders of the preferred stock, or any series of preferred stock, unless a vote of any such holders is required pursuant to any preferred stock designation.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The rights and terms relating to any new series of preferred stock could adversely affect the voting power or other rights of the holders of the common stock or could be utilized, under certain circumstances, as a method of discouraging, delaying or preventing a change in control of the Company.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Provisions of Our Certificate of Incorporation and Amended and Restated By-laws and Delaware Law That May Have Anti-Takeover Effects</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">9</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The provisions of Delaware law and our certificate of incorporation and amended and restated by-laws could discourage or make it more difficult to accomplish a proxy contest or other change in our management or the acquisition of control by a holder of a substantial amount of our voting stock. It is possible that these provisions could make it more difficult to accomplish, or could deter, transactions that stockholders may otherwise consider to be in their best interests or in our best interests. These provisions are intended to enhance the likelihood of continuity and stability in the composition of our board of directors and in the policies formulated by the board of directors and to discourage certain types of transactions that may involve an actual or threatened change of our control. These provisions are designed to reduce our vulnerability to an unsolicited acquisition proposal and to discourage certain tactics that may be used in proxy fights. Such provisions also may have the effect of preventing changes in our management.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Removal of Directors by Stockholders</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our amended and restated bylaws provide that members of our board of directors may only be removed for cause by a vote of the holders of a majority of the voting power of the outstanding shares entitled to vote on the election of the directors, voting together as a single class.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Issuance of Preferred Stock</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our board of directors is authorized, without further action by our stockholders, to issue up to 1,000,000 shares of preferred stock in one or more series, and to fix the designations, powers, preferences and the relative, participating, optional or other special rights, and any qualifications, limitations and restrictions of the shares of each series of preferred stock. The issuance of preferred stock could impede the completion of a merger, tender offer or other takeover attempt.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Stockholder Nomination of Directors</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our amended and restated bylaws provide that a stockholder must notify us in writing of any stockholder nomination of a director not earlier than 5:00 p.m., Eastern Time, on the 120th day and not later than 5:00 p.m., Eastern Time, on the 90th day prior to the first anniversary of the preceding year&#8217;s annual meeting; provided, that if there was no annual meeting in the prior year or if the date of the current year&#8217;s annual meeting is more than 30 days before or after the anniversary date of the prior year&#8217;s annual meeting, notice by the stockholder to be timely must be so delivered on or before 10 days after the day on which the date of the current year&#8217;s annual meeting is first disclosed in a public announcement by us.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">No Action By Written Consent</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our certificate of incorporation provides that our stockholders may not act by written consent and may only act at duly called meetings of stockholders.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Delaware Business Combination Statute</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Section 203 of the General Corporation Law of the State of Delaware, which we refer to as the DGCL, is applicable to us. Section 203 of the DGCL restricts some types of transactions and business combinations between a corporation and a 15% stockholder. A 15% stockholder is generally considered by Section 203 to be a person owning 15% or more of the corporation&#8217;s outstanding voting stock. Section 203 refers to a 15% stockholder as an &#8220;interested stockholder.&#8221; Section 203 restricts these transactions for a period of three years from the date the stockholder acquires 15% or more of our outstanding voting stock. With some exceptions, unless the transaction is approved by the board of directors and the holders of at least two-thirds of the outstanding voting stock of the corporation, Section 203 prohibits significant business transactions such as:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a merger with, disposition of significant assets to or receipt of disproportionate financial benefits by the interested stockholder, and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any other transaction that would increase the interested stockholder&#8217;s proportionate ownership of any class or series of our capital stock.</font></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">10</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The shares held by the interested stockholder are not counted as outstanding when calculating the two-thirds of the outstanding voting stock needed for approval.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">prohibition does not apply if:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">prior to the time that any stockholder became an interested stockholder, the board of directors approved either the business combination or the transaction in which such stockholder acquired 15% or more of our outstanding voting stock, or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the interested stockholder owns at least 75% of our outstanding voting stock as a result of a transaction in which such stockholder acquired 15% or more of our outstanding voting stock. Shares held by persons who are both directors and officers or by some types of employee stock plans are not counted as outstanding when making this calculation.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;">Choice of forum</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for any state law claim for: (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed by any of our directors or officers or other employees to us or to our stockholders, (iii) any action asserting a claim against us or any of our directors or officers or other employees arising pursuant to any provision of the DGCL or our certificate of incorporation or our amended and restated bylaws (any of which may be amended from time to time), or (iv) any action asserting a claim against us or any of our directors or officers or other employees governed by the internal affairs doctrine. This exclusive forum provision would not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act or any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">11</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DESCRIPTION OF DEBT SECURITIES</b><a name="DESCRIPTIONOFDEBTSECURITIES_48288"></a><a name="DESCRIPTIONOFDEBTSECURITIES_PROSP"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may offer debt securities that may be senior or subordinated. We refer to senior debt securities and subordinated debt securities collectively as debt securities. Each series of debt securities may have different terms. The following description summarizes the general terms and provisions of the debt securities we might issue. We will describe the specific terms of the debt securities we offer for sale and the extent, if any, to which the general provisions summarized below apply to any series of debt securities in the prospectus supplement relating to the series and any applicable free writing prospectus that we authorize to be delivered.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may issue senior debt securities from time to time, in one or more series under a senior indenture to be entered into between us and a senior trustee to be named in a prospectus supplement, which we refer to as the senior trustee. We may issue subordinated debt securities from time to time, in one or more series, under a subordinated indenture to be entered into between us and a subordinated trustee to be named in a prospectus supplement, which we refer to as the subordinated trustee. The forms of senior indenture and subordinated indenture are filed as exhibits to the registration statement of which this prospectus forms a part. Together, the senior indenture and the subordinated indenture are referred to as the indentures and, together, the senior trustee and the subordinated trustee are referred to as the trustees. This prospectus briefly outlines some of the provisions of the indentures. The following summary of the material provisions of the indentures is qualified in its entirety by the provisions of the indentures, including definitions of certain terms used in the indentures. Wherever we refer to particular sections or defined terms of the indentures, those sections or defined terms are incorporated by reference in this prospectus or the applicable prospectus supplement. You should review the indentures that are filed as exhibits to the registration statement of which this prospectus forms a part for additional information. As used in this prospectus, the term &#8220;debt securities&#8221; includes the debt securities being offered by this prospectus and all other debt securities issued by us under the indentures.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">General</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The indentures:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">do not limit the amount of debt securities that we may issue;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">allow us to issue debt securities in one or more series;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">do not require us to issue all of the debt securities of a series at the same time; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">allow us to reopen a series to issue additional debt securities without the consent of the holders of the debt securities of such series.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise provided in the applicable prospectus supplement, the senior debt securities will be unsubordinated obligations and will rank equally with all of our other unsecured and unsubordinated indebtedness. Payments on the subordinated debt securities will be subordinated to the prior payment in full of all of our senior indebtedness, as described under &#8220;Subordination&#8221; and in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each indenture provides that we may, but need not, designate more than one trustee under an indenture. Any trustee under an indenture may resign or be removed and a successor trustee may be appointed to act with respect to the series of debt securities administered by the resigning or removed trustee. If two or more persons are acting as trustee with respect to different series of debt securities, each trustee shall be a trustee of a trust under the applicable indenture separate and apart from the trust administered by any other trustee. Except as otherwise indicated in this prospectus, any action described in this prospectus to be taken by each trustee may be taken by each trustee with respect to, and only with respect to, the one or more series of debt securities for which it is trustee under the applicable indenture.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The prospectus supplement for each offering will provide the following terms, where applicable:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the title of the debt securities and whether they are senior or subordinated;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any limit upon the aggregate principal amount of the debt securities of that series;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the date or dates on which the principal of the debt securities of the series is payable;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the price at which the debt securities will be issued, expressed as a percentage of the principal and, if other than the principal amount thereof, the portion of the principal amount thereof payable upon declaration of acceleration of the maturity thereof or, if applicable, the portion of the principal amount of such debt securities that is convertible into another security of ours or the method by which any such portion shall be determined;</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">12</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the rate or rates at which the debt securities of the series shall bear interest or the manner of calculation of such rate or rates, if any;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the date or dates from which interest will accrue, the interest payment dates on which such interest will be payable or the manner of determination of such interest payment dates, the place(s) of payment, and the record date for the determination of holders to whom interest is payable on any such interest payment dates or the manner of determination of such record dates;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the right, if any, to extend the interest payment periods and the duration of such extension;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the period or periods within which, the price or prices at which and the terms and conditions upon which debt securities of the series may be redeemed, converted or exchanged, in whole or in part;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our obligation, if any, to redeem or purchase debt securities of the series pursuant to any sinking fund, mandatory redemption, or analogous provisions (including payments made in cash in satisfaction of future sinking fund obligations) or at the option of a holder thereof and the period or periods within which, the price or prices at which, and the terms and conditions upon which, debt securities of the series shall be redeemed or purchased, in whole or in part, pursuant to such obligation;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the form of the debt securities of the series including the form of the Certificate of Authentication for such series;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if other than minimum denominations of one thousand U.S. dollars ($1,000) or any integral multiple of $1,000 thereof, the denominations in which the debt securities of the series shall be issuable;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">whether the debt securities of the series shall be issued in whole or in part in the form of a global debt security or global debt securities; the terms and conditions, if any, upon which such global debt security or global debt securities may be exchanged in whole or in part for other individual debt securities; and the depositary for such global debt security or global debt securities;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">whether</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the debt securities will be convertible into or exchangeable for common stock or other securities of ours or any other Person and, if so, the terms and conditions upon which such debt securities will be so convertible or exchangeable, including the conversion or exchange price, as applicable, or how it will be calculated and may be adjusted, any mandatory or optional (at our option or the holders&#8217; option) conversion or exchange features, and the applicable conversion or exchange period;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any additional or alternative events of default to those set forth in the indenture;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any additional or alternative covenants to those set forth in the indenture;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the currency or currencies including composite currencies, in which payment of the principal of (and premium, if any) and interest, if any, on such debt securities shall be payable (if other than the currency of the United States of America), which unless otherwise specified shall be the currency of the United States of America as at the time of payment is legal tender for payment of public or private debts;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the principal of (and premium, if any), or interest, if any, on such debt securities is to be payable, at our election or at the election of any holder thereof, in a coin or currency other than that in which such debt securities are stated to be payable, then the period or periods within which, and the terms and conditions upon which, such election may be made;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">whether interest will be payable in cash or additional debt securities at our or the holders&#8217; option and the terms and conditions upon which the election may be made;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the terms and conditions, if any, upon which we will pay amounts in addition to the stated interest, premium, if any and principal amounts of the debt securities of the series to any holder that is not a &#8220;United States person&#8221; for federal tax purposes;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">additional or alternative provisions, if any, related to defeasance and discharge of the offered debt securities than those set forth in the indenture;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the applicability of any guarantees;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any restrictions on transfer, sale or assignment of the debt securities of the series; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any other terms of the debt securities (which may supplement, modify or delete any provision of the indenture insofar as it applies to such series).</font></td></tr></table><div style="margin-top:12pt;"></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">13</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may issue debt securities that provide for less than the entire principal amount thereof to be payable upon declaration of acceleration of the maturity of the debt securities. We refer to any such debt securities throughout this prospectus as &#8220;original issue discount securities.&#8221;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will provide you with more information in the applicable prospectus supplement regarding any deletions, modifications, or additions to the events of default or covenants that are described below, including any addition of a covenant or other provision providing event risk or similar protection.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Payment</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise provided in the applicable prospectus supplement, the principal of, and any premium or make-whole amount, and interest on, any series of the debt securities will be payable by mailing a check to the address of the person entitled to it as it appears in the applicable register for the debt securities or by wire transfer of funds to that person at an account maintained within the United States.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">All monies that we pay to a paying agent or a trustee for the payment of the principal of, and any premium, or interest on, any debt security will be repaid to us if unclaimed at the end of two years after the obligation underlying payment becomes due and payable. After funds have been returned to us, the holder of the debt security may look only to us for payment, without payment of interest for the period which we hold the funds.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Merger, Consolidation or Sale of Assets</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The indentures provide that we may, without the consent of the holders of any outstanding debt securities, (i) consolidate with, (ii) sell, lease or convey all or substantially all of our assets to, or (iii) merge with or into, any other entity, provided that:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">either we are the continuing entity, or the successor entity, if other than us, assumes the obligations (a) to pay the principal of, and any premium, and interest on, all of the debt securities and (b) to duly perform and observe all of the covenants and conditions contained in the applicable indenture; and in the event the debt securities are convertible into or exchangeable for common stock or other securities of ours, such successor entity will, by such supplemental indenture, make provision so that the holders of debt securities of that series shall thereafter be entitled to receive upon conversion or exchange of such debt securities the number of securities or property to which a holder of the number of common stock or other securities of ours deliverable upon conversion or exchange of those debt securities would have been entitled had such conversion or exchange occurred immediately prior to such consolidation, merger, sale, conveyance, transfer or other disposition; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">an officers&#8217; certificate and legal opinion covering such conditions are delivered to each applicable trustee.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Events of Default, Notice and Waiver</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless the applicable prospectus supplement states otherwise, when we refer to &#8220;events of default&#8221; as defined in the indentures with respect to any series of debt securities, we mean:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">default in the payment of any installment of interest on any debt security of such series continuing for 90 days unless such date has been extended or deferred;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">default in the payment of principal of, or any premium on, any debt security of such series when due and payable unless such date has been extended or deferred;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">default in the performance or breach of any covenant or warranty in the debt securities or in the indenture by us continuing for 90 days after written notice described below;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">bankruptcy insolvency or reorganization, or court appointment of a receiver, liquidator or trustee of us; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any other event of default provided with respect to a particular series of debt securities.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">If an event of default (other than an event of default described in the fourth bullet point above) occurs and is continuing with respect to debt securities of any series outstanding, then the applicable trustee or the holders of 25% or more in principal amount of the debt securities of that series will have the right to declare the principal amount of, and accrued interest on, all the debt securities of that series to be due and payable. If an event of default described in the fourth bullet point above occurs, the principal amount of, and accrued interest on, all the debt securities of that series will </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">14</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">automatically become and will be immediately due and payable without any declaration or other act on the part of the trustee or the holders of the debt securities. However, at any time after such a declaration of acceleration has been made, but before a judgment or decree for payment of the money due has been obtained by the applicable trustee, the holders of at least a majority in principal amount of outstanding debt securities of such series or of all debt securities then outstanding under the applicable indenture may rescind and annul such declaration and its consequences if:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we have deposited with the applicable trustee all required payments of the principal, any premium, interest and, to the extent permitted by law, interest on overdue installment of interest, plus applicable fees, expenses, disbursements and advances of the applicable trustee; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all events of default, other than the non-payment of accelerated principal, or a specified portion thereof, and any premium, have been cured or waived.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The indentures provide that holders of debt securities of any series may not institute any proceedings, judicial or otherwise, with respect to such indenture or for any remedy under the indenture, unless the trustee fails to act for a period of 90 days after the trustee has received a written request to institute proceedings in respect of an event of default from the holders of 25% or more in principal amount of the outstanding debt securities of such series, as well as an offer of indemnity reasonably satisfactory to the trustee. However, this provision will not prevent any holder of debt securities from instituting suit for the enforcement of payment of the principal of, and any premium, and interest on, such debt securities at the respective due dates thereof.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The indentures provide that, subject to provisions in each indenture relating to its duties in the case of a default, a trustee has no obligation to exercise any of its rights or powers at the request or direction of any holders of any series of debt securities then outstanding under the indenture, unless the holders have offered to the trustee reasonable security or indemnity. The holders of at least a majority in principal amount of the outstanding debt securities of any series or of all debt securities then outstanding under an indenture shall have the right to direct the time, method and place of conducting any proceeding for any remedy available to the applicable trustee, or of exercising any trust or power conferred upon such trustee. However, a trustee may refuse to follow any direction which:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">is in conflict with any law or the applicable indenture;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">may involve the trustee in personal liability; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">may be unduly prejudicial to the holders of debt securities of the series not joining the proceeding.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Within 120 days after the close of each fiscal year, we will be required to deliver to each trustee a certificate, signed by one of our several specified officers, stating whether or not that officer has knowledge of any default under the applicable indenture. If the officer has knowledge of any default, the notice must specify the nature and status of the default.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Modification of the Indentures</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Subject to certain exceptions, the indentures may be amended with the consent of the holders of a majority in aggregate principal amount of the outstanding debt securities of all series affected by such amendment (including consents obtained in connection with a tender offer or exchange for the debt securities of such series).</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">and the applicable trustee may make modifications and amendments of an indenture without the consent of any holder of debt securities for any of the following purposes:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to cure any ambiguity, defect, or inconsistency in the applicable indenture or in the Securities of any series;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to comply with the covenant described above under &#8220;Merger, Consolidation or Sale of Assets;&#8221;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to provide for uncertificated debt securities in addition to or in place of certificated debt securities;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to add events of default for the benefit of the holders of all or any series of debt securities;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to add the covenants, restrictions, conditions or provisions relating to us for the benefit of the holders of all or any series of debt securities (and if such covenants, restrictions, conditions or provisions are to be for the benefit of less than all series of debt securities, stating that such covenants, restrictions, conditions or provisions are expressly being included solely for the benefit of such series), to make the occurrence, or the occurrence and the continuance, of a default in any such additional covenants, restrictions, conditions or provisions an event of default, or to surrender any right or power in the applicable indenture conferred upon us;</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">15</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to add to, delete from, or revise the conditions, limitations, and restrictions on the authorized amount, terms, or purposes of issue, authentication, and delivery of debt securities, as set forth in the applicable indenture;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to make any change that does not adversely affect the rights of any holder of notes under the applicable indenture in any material respect;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to provide for the issuance of and establish the form and terms and conditions of the debt securities of any series as provided in the applicable indenture, to establish the form of any certifications required to be furnished pursuant to the terms of the applicable indenture or any series of debt securities under the applicable indenture, or to add to the rights of the holders of any series of debt securities;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to evidence and provide for the acceptance of appointment under the applicable indenture by a successor trustee or to appoint a separate trustee with respect to any series;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">comply with any requirements of the SEC or any successor in connection with the qualification of the indenture under the Trust Indenture Act of 1939, as amended, or the Trust Indenture Act; or </font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to conform the applicable indenture to this &#8220;Description of Debt Securities&#8221; or any other similarly titled section in any prospectus supplement or other offering document relating to a series of debt securities.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Subordination</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Payment</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">by us of the principal of, premium, if any, and interest on any series of subordinated debt securities issued under the subordinated indenture will be subordinated to the extent set forth in an indenture supplemental to the subordinated indenture relating to such series.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Discharge, Defeasance and Covenant Defeasance</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise provided in the applicable prospectus supplement, the indentures allow us to discharge our obligations to holders of any series of debt securities issued under any indenture when:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">either (i) all securities of such series have already been delivered to the applicable trustee for cancellation; or (ii) all securities of such series have not already been delivered to the applicable trustee for cancellation but (a) have become due and payable, (b) will become due and payable within one year, or (c) if redeemable at our option, are to be redeemed within one year, and we have irrevocably deposited with the applicable trustee, in trust, funds in such currency or currencies, or governmental obligations in an amount sufficient to pay the entire indebtedness on such debt securities in respect of principal and any premium, and interest to the date of such deposit if such debt securities have become due and payable or, if they have not, to the stated maturity or redemption date; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">we have paid or caused to be paid all other sums payable.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Unless otherwise provided in the applicable prospectus supplement, the indentures provide that, upon our irrevocable deposit with the applicable trustee, in trust, of an amount, in such currency or currencies in which such debt securities are payable at stated maturity, or government obligations, or both, applicable to such debt securities, which through the scheduled payment of principal and interest in accordance with their terms will provide money in an amount sufficient to pay the principal of, and any premium or make-whole amount, and interest on, such debt securities, and any mandatory sinking fund or analogous payments thereon, on the scheduled due dates therefor, the issuing company shall be released from its obligations with respect to such debt securities under the applicable indenture or, if provided in the applicable prospectus supplement, its obligations with respect to any other covenant, and any omission to comply with such obligations shall not constitute an event of default with respect to such debt securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The</font><font style="font-family:'Times New Roman','Times','serif';"> </font><font style="font-family:'Times New Roman','Times','serif';">applicable prospectus supplement may further describe the provisions, if any, permitting such defeasance or covenant defeasance, including any modifications to the provisions described above, with respect to the debt securities of or within a particular series.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Conversion Rights</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The terms and conditions, if any, upon which the debt securities are convertible into common stock or other securities of ours will be set forth in the applicable prospectus supplement. The terms will include whether the debt securities are convertible into shares of common stock or other securities of ours, the conversion price, or manner of calculation </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">16</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">thereof, the conversion period, provisions as to whether conversion will be at the issuing company&#8217;s option or the option of the holders, the events requiring an adjustment of the conversion price and provisions affecting conversion in the event of the redemption of the debt securities and any restrictions on conversion.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Governing Law</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The indentures and the debt securities will be governed by and construed in accordance with the laws of the State of New York, except to the extent that the Trust Indenture Act is applicable.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">17</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DESCRIPTION OF WARRANTS</b><a name="DESCRIPTIONOFWARRANTS_481136"></a><a name="DESCRIPTIONOFWARRANTS_PROSP"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The following description, together with the additional information we may include in any applicable prospectus supplements, summarizes the material terms and provisions of the warrants that we may offer under this prospectus and the related warrant agreements and warrant certificates. While the terms summarized below will apply generally to any warrants that we may offer, we will describe the particular terms of any series of warrants in more detail in the applicable prospectus supplement. If we indicate in the applicable prospectus supplement, the terms of any warrants offered under that prospectus supplement may differ from the terms described below. Specific warrant agreements will contain additional important terms and provisions and will be incorporated by reference as an exhibit to the registration statement, which includes this prospectus.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">General</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may issue warrants for the purchase of common stock, preferred stock and/or debt securities in one or more series. We may issue warrants independently or together with common stock, preferred stock and/or debt securities, and the warrants may be attached to or separate from these securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will evidence each series of warrants by warrant certificates that we will issue under a separate warrant agreement. We will enter into the warrant agreement with a warrant agent. We will indicate the name and address of the warrant agent in the applicable prospectus supplement relating to a particular series of warrants.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will describe in the applicable prospectus supplement the terms of the series of warrants, including:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the offering price and aggregate number of warrants offered;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the currency for which the warrants may be purchased;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if applicable, the designation and terms of the securities with which the warrants are issued and the number of warrants issued with each such security or each principal amount of such security;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if applicable, the date on and after which the warrants and the related securities will be separately transferable;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in the case of warrants to purchase debt securities, the principal amount of debt securities purchasable upon exercise of one warrant and the price at, and currency in which, this principal amount of debt securities may be purchased upon such exercise;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">in the case of warrants to purchase common stock or preferred stock, the number of shares of common stock or preferred stock, as the case may be, purchasable upon the exercise of one warrant and the price at which these shares may be purchased upon such exercise;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the effect of any merger, consolidation, sale or other disposition of our business on the warrant agreement and the warrants;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the terms of any rights to redeem or call the warrants;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any provisions for changes to or adjustments in the exercise price or number of securities issuable upon exercise of the warrants;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the periods during which, and places at which, the warrants are exercisable;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the manner of exercise;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the dates on which the right to exercise the warrants will commence and expire;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the manner in which the warrant agreement and warrants may be modified;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">federal income tax consequences of holding or exercising the warrants;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the terms of the securities issuable upon exercise of the warrants; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any other specific terms, preferences, rights or limitations of or restrictions on the warrants</font><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">18</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">DESCRIPTION OF UNITS</b><a name="DESCRIPTIONOFUNITS_569510"></a><a name="DESCRIPTIONOFUNITS_PROSP"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may issue units comprised of shares of common stock, shares of preferred stock, debt securities and warrants in any combination. We may issue units in such amounts and in as many distinct series as we wish. This section outlines certain provisions of the units that we may issue. If we issue units, they will be issued under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. The information described in this section may not be complete in all respects and is qualified entirely by reference to the unit agreement with respect to the units of any particular series. The specific terms of any series of units offered will be described in the applicable prospectus supplement. If so described in a particular prospectus supplement, the specific terms of any series of units may differ from the general description of terms presented below. We urge you to read any prospectus supplement related to any series of units we may offer, as well as the complete unit agreement and unit certificate that contain the terms of the units. If we issue units, forms of unit agreements and unit certificates relating to such units will be incorporated by reference as exhibits to the registration statement, which includes this prospectus.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each unit that we may issue will be issued so that the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations of a holder of each included security. The unit agreement under which a unit is issued may provide that the securities included in the unit may not be held or transferred separately, at any time or at any time before a specified date. The applicable prospectus supplement may describe:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the designation and terms of the units and of the securities comprising the units, including whether and under what circumstances those securities may be held or transferred separately;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any provisions of the governing unit agreement;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the price or prices at which such units will be issued;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the applicable United States federal income tax considerations relating to the units;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities comprising the units; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any other terms of the units and of the securities comprising the units.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The provisions described in this section, as well as those described under &#8220;Description of Capital Stock,&#8221; &#8220;Description of Debt Securities&#8221; and &#8220;Description of Warrants&#8221; will apply to the securities included in each unit, to the extent relevant and as may be updated in any prospectus supplements.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Issuance in Series</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may issue units in such amounts and in as many distinct series as we wish. This section summarizes terms of the units that apply generally to all series. Most of the financial and other specific terms of a particular series of units will be described in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Unit Agreements</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will issue the units under one or more unit agreements to be entered into between us and a bank or other financial institution, as unit agent. We may add, replace or terminate unit agents from time to time. We will identify the unit agreement under which each series of units will be issued and the unit agent under that agreement in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The following provisions will generally apply to all unit agreements unless otherwise stated in the applicable prospectus supplement:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Modification without Consent</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We and the applicable unit agent may amend any unit or unit agreement without the consent of any holder:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to cure any ambiguity, including modifying any provisions of the governing unit agreement that differ from those described below;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to correct or supplement any defective or inconsistent provision; or</font></td></tr></table></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">19</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">to make any other change that we believe is necessary or desirable and will not adversely affect the interests of the affected holders in any material respect.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We do not need any approval to make changes that affect only units to be issued after the changes take effect. We may also make changes that do not adversely affect a particular unit in any material respect, even if they adversely affect other units in a material respect. In those cases, we do not need to obtain the approval of the holder of the unaffected unit; we need only obtain any required approvals from the holders of the affected units.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Modification with Consent</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may not amend any particular unit or a unit agreement with respect to any particular unit unless we obtain the consent of the holder of that unit, if the amendment would:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">impair any right of the holder to exercise or enforce any right under a security included in the unit if the terms of that security require the consent of the holder to any changes that would impair the exercise or enforcement of that right; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reduce the percentage of outstanding units or any series or class the consent of whose holders is required to amend that series or class, or the applicable unit agreement with respect to that series or class, as described below.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Any other change to a particular unit agreement and the units issued under that agreement would require the following approval:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the change affects only the units of a particular series issued under that agreement, the change must be approved by the holders of a majority of the outstanding units of that series; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the change affects the units of more than one series issued under that agreement, it must be approved by the holders of a majority of all outstanding units of all series affected by the change, with the units of all the affected series voting together as one class for this purpose.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">These provisions regarding changes with majority approval also apply to changes affecting any securities issued under a unit agreement, as the governing document.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In each case, the required approval must be given by written consent.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Unit Agreements will not be Qualified Under Trust Indenture Act</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">No unit agreement will be qualified as an indenture, and no unit agent will be required to qualify as a trustee, under the Trust Indenture Act. Therefore, holders of units issued under unit agreements will not have the protections of the Trust Indenture Act with respect to their units.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Mergers and Similar Transactions Permitted; No Restrictive Covenants or Events of Default</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The unit agreements will not restrict our ability to merge or consolidate with, or sell our assets to, another corporation or other entity or to engage in any other transactions. If at any time we merge or consolidate with, or sell our assets substantially as an entirety to, another corporation or other entity, the successor entity will succeed to and assume our obligations under the unit agreements. We will then be relieved of any further obligation under these agreements.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The unit agreements will not include any restrictions on our ability to put liens on our assets, nor will they restrict our ability to sell our assets. The unit agreements also will not provide for any events of default or remedies upon the occurrence of any events of default.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Governing Law</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The unit agreements and the units will be governed by Delaware law.</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">20</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Form, Exchange and Transfer</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We will issue each unit in global&#8212;i.e., book-entry&#8212;form only. Units in book-entry form will be represented by a global security registered in the name of a depositary, which will be the holder of all the units represented by the global security. Those who own beneficial interests in a unit will do so through participants in the depositary&#8217;s system, and the rights of these indirect owners will be governed solely by the applicable procedures of the depositary and its participants. We will describe book-entry securities, and other terms regarding the issuance and registration of the units in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each unit and all securities comprising the unit will be issued in the same form.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">If we issue any units in registered, non-global form, the following will apply to them. The units will be issued in the denominations stated in the applicable prospectus supplement. Holders may exchange their units for units of smaller denominations or combined into fewer units of larger denominations, as long as the total amount is not changed.</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">holders may exchange or transfer their units at the office of the unit agent. Holders may also replace lost, stolen, destroyed or mutilated units at that office. We may appoint another entity to perform these functions or perform them ourselves.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">holders will not be required to pay a service charge to transfer or exchange their units, but they may be required to pay for any tax or other governmental charge associated with the transfer or exchange. The transfer or exchange, and any replacement, will be made only if our transfer agent is satisfied with the holder&#8217;s proof of legal ownership. The transfer agent may also require an indemnity before replacing any units.</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if we have the right to redeem, accelerate or settle any units before their maturity, and we exercise our right as to less than all those units or other securities, we may block the exchange or transfer of those units during the period beginning 15 days before the day we mail the notice of exercise and ending on the day of that mailing, in order to freeze the list of holders to prepare the mailing. We may also refuse to register transfers of or exchange any unit selected for early settlement, except that we will continue to permit transfers and exchanges of the unsettled portion of any unit being partially settled. We may also block the transfer or exchange of any unit in this manner if the unit includes securities that are or may be selected for early settlement.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Only the depositary will be entitled to transfer or exchange a unit in global form, since it will be the sole holder of the unit.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-style:italic;">Payments and Notices</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:18pt;margin:0pt;"><font style="margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In making payments and giving notices with respect to our units, we will follow the procedures as described in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">21</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">PLAN OF DISTRIBUTION</b><a name="PLANOFDISTRIBUTION_971168"></a><a name="PLANOFDISTRIBUTION_PROSP"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may sell securities:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">through underwriters;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">through dealers;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">through agents;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">directly to purchasers; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">through a combination of any of these methods or any other method permitted by law.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In addition, we may issue the securities as a dividend or distribution or in a subscription rights offering to our existing security holders.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may directly solicit offers to purchase securities, or we may designate agents to solicit these offers. In the prospectus supplement relating to such an offering, we will name any agent that could be viewed as an underwriter under the Securities Act and describe any commissions that we must pay to any such agent. Any such agent will be acting on a best efforts basis for the period of its appointment or, if indicated in the applicable prospectus supplement, on a firm commitment basis. This prospectus may be used in connection with any offering of our securities through any of these methods or other methods described in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The distribution of the securities may be effected from time to time in one or more transactions:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at a fixed price, or prices, which may be changed from time to time;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at market prices prevailing at the time of sale;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at prices related to such prevailing market prices; or</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">at negotiated prices.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Each prospectus supplement will describe the method of distribution of the securities and any applicable restrictions.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">The prospectus supplement with respect to the securities of a particular series will describe the terms of the offering of the securities, including the following:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the name of the agent or any underwriters;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the public offering or purchase price;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any discounts and commissions to be allowed or paid to the agent or underwriters;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all other items constituting underwriting compensation;</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any discounts and commissions to be allowed or paid to dealers; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any exchanges on which the securities will be listed.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If any underwriters or agents are used in the sale of the securities in respect of which this prospectus is delivered, we will enter into an underwriting agreement, equity distribution agreement or other agreement with them at the time of sale to them, and we will set forth in the prospectus supplement relating to such offering the names of the underwriters or agents and the terms of the related agreement with them.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In connection with the offering of securities, we may grant to the underwriters an option to purchase additional securities with an additional underwriting commission, as may be set forth in the accompanying prospectus supplement. If we grant any such option, the terms of such option will be set forth in the prospectus supplement for such securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">If a dealer is used in the sale of the securities in respect of which the prospectus is delivered, we will sell such securities to the dealer, as principal. The dealer, who may be deemed to be an &#8220;underwriter&#8221; as that term is defined in the Securities Act, may then resell such securities to the public at varying prices to be determined by such dealer at the time of resale.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">If we offer securities in a subscription rights offering to our existing security holders, we may enter into a standby underwriting agreement with dealers, acting as standby underwriters. We may pay the standby underwriters a commitment fee for the securities they commit to purchase on a standby basis. If we do not enter into a standby </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">22</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">underwriting arrangement, we may retain a dealer-manager to manage a subscription rights offering for us. Agents, underwriters, dealers and other persons may be entitled under agreements which they may enter into with us to indemnification by us against certain civil liabilities, including liabilities under the Securities Act, and may be customers of, engage in transactions with or perform services for us in the ordinary course of business.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">If so indicated in the applicable prospectus supplement, we will authorize underwriters or other persons acting as our agents to solicit offers by certain institutions to purchase securities from us pursuant to delayed delivery contracts providing for payment and delivery on the date stated in the prospectus supplement. Each contract will be for an amount not less than, and the aggregate amount of securities sold pursuant to such contracts shall not be less nor more than, the respective amounts stated in the prospectus supplement. Institutions with whom the contracts, when authorized, may be made include commercial and savings banks, insurance companies, pension funds, investment companies, educational and charitable institutions and other institutions, but shall in all cases be subject to our approval. Delayed delivery contracts will not be subject to any conditions except that:</font></p><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the purchase by an institution of the securities covered under that contract shall not at the time of delivery be prohibited under the laws of the jurisdiction to which that institution is subject; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">if the securities are also being sold to underwriters acting as principals for their own account, the underwriters shall have purchased such securities not sold for delayed delivery. The underwriters and other persons acting as our agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Offered securities may also be offered and sold, if so indicated in the prospectus supplement, in connection with a remarketing upon their purchase, in accordance with a redemption or repayment pursuant to their terms, or otherwise, by one or more remarketing firms, acting as principals for their own accounts or as agents for us. Any remarketing firm will be identified and the terms of its agreement, if any, with us and its compensation will be described in the applicable prospectus supplement. Remarketing firms may be deemed to be underwriters in connection with their remarketing of offered securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Certain agents, underwriters and dealers, and their associates and affiliates, may be customers of, have borrowing relationships with, engage in other transactions with, or perform services, including investment banking services, for us or one or more of our respective affiliates in the ordinary course of business.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">In order to facilitate the offering of the securities, any underwriters may engage in transactions that stabilize, maintain or otherwise affect the price of the securities or any other securities the prices of which may be used to determine payments on such securities. Specifically, any underwriters may over-allot in connection with the offering, creating a short position for their own accounts. In addition, to cover overallotments or to stabilize the price of the securities or of any such other securities, the underwriters may bid for, and purchase, the securities or any such other securities in the open market. Finally, in any offering of the securities through a syndicate of underwriters, the underwriting syndicate may reclaim selling concessions allowed to an underwriter or a dealer for distributing the securities in the offering if the syndicate repurchases previously distributed securities in transactions to cover syndicate short positions, in stabilization transactions or otherwise. Any of these activities may stabilize or maintain the market price of the securities above independent market levels. Any such underwriters are not required to engage in these activities and may end any of these activities at any time.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">We may engage in at the market offerings into an existing trading market in accordance with Rule 415(a)(4) under the Securities Act. In addition, we may enter into derivative transactions with third parties, or sell securities not covered by this prospectus to third parties in privately negotiated transactions. If the applicable prospectus supplement so indicates, in connection with those derivatives, the third parties may sell securities covered by this prospectus and the applicable prospectus supplement, including in short sale transactions. If so, the third party may use securities pledged by us or borrowed from us or others to settle those sales or to close out any related open borrowings of stock, and may use securities received from us in settlement of those derivatives to close out any related open borrowings of stock. The third party in such sale transactions will be an underwriter and, if not identified in this prospectus, will be named in the applicable prospectus supplement (or a post-effective amendment). In addition, we may otherwise loan or pledge securities to a financial institution or other third party that in turn may sell the securities short using this prospectus and </font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">23</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">an applicable prospectus supplement. Such financial institution or other third party may transfer its economic short position to investors in our securities or in connection with a concurrent offering of other securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Under Rule 15c6-1 of the Exchange Act, trades in the secondary market generally are required to settle in one business day, unless the parties to any such trade expressly agree otherwise. The applicable prospectus supplement may provide that the original issue date for your securities may be more than one scheduled business day after the trade date for your securities. Accordingly, in such a case, if you wish to trade securities on any date prior to the first business day before the original issue date for your securities, you will be required, by virtue of the fact that your securities initially are expected to settle in more than one scheduled business day after the trade date for your securities, to make alternative settlement arrangements to prevent a failed settlement. The securities may be new issues of securities and may have no established trading market. The securities may or may not be listed on a national securities exchange. We can make no assurance as to the liquidity of or the existence of trading markets for any of the securities.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The specific terms of any lock-up provisions in respect of any given offering will be described in the applicable prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The underwriters, dealers and agents may engage in transactions with us, or perform services for us, in the ordinary course of business for which they receive compensation.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The anticipated date of delivery of offered securities will be set forth in the applicable prospectus supplement relating to each offer.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-weight:bold;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">24</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">LEGAL MATTERS</b><a name="LEGAL_784747"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Certain legal matters in connection with this offering will be passed upon for us by Goodwin Procter LLP, Boston, Massachusetts. Any underwriters will also be advised about the validity of the securities and other legal matters by their own counsel, which will be named in the prospectus supplement.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">EXPERTS</b><a name="EXP_372498"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The consolidated financial statements of Altimmune, Inc. appearing in Altimmune, Inc.&#8217;s Annual Report (Form 10-K) for the year ended December 31, 2024 have been audited by Ernst &amp; Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">25</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">WHERE YOU CAN FIND MORE INFORMATION</b><a name="WHEREYOU_668710"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This </font><font style="font-family:'Times New Roman','Times','serif';">prospectus is part of a registration statement we filed with the SEC. This prospectus does not contain all of the information set forth in the registration statement and the exhibits to the registration statement. For further information with respect to us and the securities we are offering under this prospectus, we refer you to the registration statement and the exhibits and schedules filed as a part of the registration statement. You should rely only on the information contained in this prospectus or incorporated by reference. We have not authorized anyone else to provide you with different information. We are not making an offer of these securities in any state where the offer is not permitted. You should not assume that the information in this prospectus is accurate as of any date other than the date on the front page of this prospectus, regardless of the time of delivery of this prospectus or any sale of the securities offered by this prospectus.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We file annual, quarterly and current reports, proxy statements, and other information with the SEC. The SEC maintains a web site at http://www.sec.gov that contains reports, proxy statements and other information about issuers, such as us, who file electronically with the SEC. The address of the SEC website is www.sec.gov.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We maintain a website at http://www.altimmune.com. The information contained on, or accessible through, our website is not incorporated by reference into this prospectus and, therefore is not part of this prospectus or part of the accompanying prospectus supplement</font><font style="font-family:'Times New Roman','Times','serif';">.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">26</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">INCORPORATION BY REFERENCE</b><a name="INCORPORATI_88026"></a></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">The SEC allows us to incorporate by reference much of the information we file with the SEC, which means that we can disclose important information to you by referring you to those publicly available documents. The information that we incorporate by reference in this prospectus is considered to be part of this prospectus.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">Because we are incorporating by reference future filings with the SEC, this prospectus is continually updated and those future filings may modify or supersede some of the information included or incorporated in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any document previously incorporated by reference have been modified or superseded. This prospectus incorporates by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (in each case, other than those documents or the portions of those documents not deemed to be filed) between the date of the initial registration statement and the effectiveness of the registration statement and following the effectiveness of the registration statement until the offering of the securities under the registration statement is terminated or completed:</font></p><div style="margin-top:6.5pt;"></div><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 27, 2025 (the &#8220;</font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000015/alt-20241231x10k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">2024 10-K</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">&#8221;);</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:6.5pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our Current Reports on Form 8-K, as filed with the SEC on </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000003/alt-20250224x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">February 25, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> and </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000011/alt-20250224x8k.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">February 27, 2025</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">; and</font></td></tr></table><table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse;font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin-bottom:0pt;margin-top:6.5pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18pt;"></td><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the description of our common stock set forth in the registration statement on Form 8-A registering our common stock under Section 12 of the Exchange Act, which was filed as </font><a style="font-family:&quot;'Times New Roman','Times','serif'&quot;;font-size:10pt;" href="https://www.sec.gov/Archives/edgar/data/1326190/000132619025000015/alt-20241231xex4d1.htm"><font style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Exhibit 4.1</font></a><font style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> to our 2024 10-K, including any amendments or reports filed for purposes of updating such description.</font></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">We also incorporate by reference into this prospectus all documents (other than current reports furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits filed on such form that are related to such items) that are filed by us with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after the date of the initial filing of the registration statement of which this prospectus forms a part and prior to effectiveness of the registration statement, and (ii) after the date of this prospectus but prior to the termination of the offering. These documents include, without limitation, Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, as well as proxy statements.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-indent:0pt;margin:0pt 0pt 12pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">You may request a copy of these filings, at no cost, by contacting us, either orally or in writing, at the following:</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Altimmune,&#160;Inc.</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">910 Clopper Road, Suite&#160;201S</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Gaithersburg, Maryland</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">Attention: Chief Financial Officer</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';">(240) 654-1450</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="display:none;font-family:'Arial','Helvetica','sans-serif';line-height:0pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:0pt;visibility:hidden;">&#8203;</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;">27</p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-bottom:30pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:always;width:79.3%;border-width:0;"><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><font style="font-style:normal;font-weight:normal;">Table of Contents</font></a></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';"><img src="alt-20251106x424b5009.jpg" alt="Graphic" style="display:inline-block;height:92.25pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:145.5pt;"></font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Up to $200,000,000</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:14pt;font-weight:bold;">Common Stock</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:6pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;visibility:hidden;">&#8203;</font></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="0.75" width="25.0%" style="background-color:#000000;color:#000000;height:1px;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:6pt 0pt 6pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">PROSPECTUS SUPPLEMENT</b></p><div style="font-family:'Arial','Helvetica','sans-serif';font-size:10.0pt;margin-bottom:12pt;min-height:1.19em;position:relative;width:100%;"><hr noshade="true" color="#000000" size="0.75" width="25.0%" style="background-color:#000000;color:#000000;height:1px;position:relative;top:0.6em;border:none;margin:0 auto;" align="center"></div><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:16pt;font-weight:bold;">Leerink Partners</b></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</font></p><p style="font-family:'Arial','Helvetica','sans-serif';font-size:9pt;text-align:center;text-indent:0pt;margin:0pt 0pt 10pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">November 6, 2025</font></p></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Arial','Helvetica','sans-serif';font-size:10pt;text-align:center;margin:24pt 0pt 0pt 0pt;"><font style="visibility:hidden;">&#8203;</font></p></div></div><hr style="background-color:#000000;clear:both;color:#000000;height:2pt;line-height:0;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border-width:0;"></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>alt-20251106x424b5001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 alt-20251106x424b5001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "B /P# 2(  A$! Q$!_\0
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MEI1V7?S9Z64Y3+#MXK%OFK2W?;R1\I?M0?LO)XDBN?%7A2#RM40&2ZLHQ@7
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M_&1#:7EQ\N\C@1N3W]#7UK,1G&17Y[_MA+X._P"%AI_PC0!UHDC4?L^#%O\
MP_B]:^QRVI_:E/ZAB5=+52_E_P" ?G^<47DM7^TL')*^DH_S>B[GK_[3G[4"
MZ ESX4\(W EUF7]U<7J'(A!ZHI[MCN.GUJA^S%^S T$MOXQ\96_FWCGSK.RN
M1EE).?,<'^+N ?QIO[+W[+0LS:^+_%UMNNO]=9V$J_<STD<>OM7U\B8_*L<9
MC*6!IO!8)_XI=_)'1E^ KYE6689BO\,.B\V*L87TIXXIU(W2OE#[C81_NFO!
MOVRO%2>'_@W>6N_;<:E(EN@#8/\ >/Z*:]TE8 'D5\#?M6>.IOBU\7;'PAHS
M":VTZ7[)&5/WYW(WD'VP%_ U[F38?ZQBXRE\,=7\CYKB'&+"X&<8_%/W5ZL]
MG_85\*'2/AA>ZM)$HEU.\+)(.K1H H_#=OKZ87I7,?#KPI%X+\%Z/HL0 %G;
M)&2HQEL?,?KG-=,M<6.K_6L54K=W^'0]++,*L'A*=#LE]_4=1117">H%%%%
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MQ1N% #?+&<\TH0 TZBE85AGEC'7\:78/4TZBF,3;0%Q03B@'- "T4A.*3>*
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M/?['WAO2=;T/Q ^H:;:7KI<(JM<0K(0-O09%?3UCIMMIMJEM:016MO']V*%
MJ@>P%/)Z=94U*4ERZV77<6$4_9IMZ'EOA_XD_#W6?BK=Z)I]FB>*X"Z2W L]
MC''WOGQS7H?B3Q;I7@[3'U#6M1@TVS4X,UPX1<^E?'WPFX_;1U_/(,ES_(5Z
M'^W9@?"S3#DC_B8)R/H:_1ZN7P>,HX?F=II?B?.8;-:BR_$8J45S0<O):%_Q
M'^V[X#TI3_9ZW^M/O*?N(2JG!Z@MP16CX*_;&\ >+3'%<W\F@SMD[;]=J#'^
MWTI?@'\&O!3?#'P_JTGAJQN+[4+"*6YEN8A,6<KS][..?2N(_:Q^ GA6U\"7
MOBC2=/@TG4+-E>7[,FQ)5X7!4<#MTK6%+*YU_JO+).]N:Z?X&4Z^<TL/]>YH
M-6ORVZ>IV7BC]M#X>:$;B.TN[G6IH6QMM(3L;Z,< CWZ57\'?MH^!/$MVEO?
M-=:%,[[$-XF8VSC!W#@"L?\ 9;^$_@CQ%\+M$\17/ANTN=2E22&62XS,K%9&
M4G:Q([>E;GQZ_9W\*>(/ VJWNFZ/::5K%I;&6&>U3RE.T$[64<'//:IE3RR%
M9X64973MS7Z^@0K9S4PZQL90:M?EL]NUSWFTO8[R!)H9%EB<!E=#D,#T(KF?
M'?Q5\,?#B$2^(-9M].WJ62.1LR.!UPHY->2_L4>+KCQ'\)?LEU)++)I=TULK
MR'JF R@>P!Q^%>5_M@V<.H_'+PC:W*^9:S)!%+'R-RM,%(R.G6N;#Y;%XZ6$
MJO2-]5UL=V*SB4,LACJ,;N5M'W>GX'J=_P#MP?#VVDC6%[^Z0D;G6WV[1ZX)
MKK-#_:B^'.N:3<7R^);:T2#_ %D=X?*D_!3][\,UJ:;\ /A]ING26</A33FB
MD!R98M['/7YCDC\Z^/\ ]J#X+Z!\,_'F@#1XFM],U0CS+8L2$VL <$G.,&NS
M"X?+,=4]C#FB^FSO8\_&8O.<MH_6*KA*/56:M?8^A=4_;;^'MH,6DE]J1!P?
M)@VCZY8BNN^'7[1_@KXE:@-/TG5=FH,H9;6Z7RV?(S\N>&_ U+H/[._P[T*%
M_LGA:Q?S5&3<H9OIC=G'X5\X?M6_!S1/A8NB>+/"B'2)3=;&@A<[2^2P8<\=
MQQ44:&6XRHL/14HR>S=M_0UQ&)SC TOK==PE!;I)IV]3[4NKLPVLDV241"Y
MZ\<UYQ\&_CSI'QGN]9M]+M+JV?2RGF_:-O.XL!C'^Z:Z7PWJTFO_  WL-3G
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M\/?$ [?VEC_R&M<=^UK_ ,G!>"/^V'_HZNQ_8(B>V^'_ (A65&C(U+HRD?\
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%#W9__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>alt-20251106x424b5005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 alt-20251106x424b5005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "Y 2,# 2(  A$! Q$!_\0
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MO@UXFAO+62867F[[/4(^"I'\+'LP_6OH_P" ?Q[@^(5E'I6JO';Z]"N".@N
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MZ/&;&< '\:\H^//QWTKX/Z TLNV[UJX4K:6"M\SG^\WHH[FN<\9_M<>"])\
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MVSU+'D,?KBOT4EM4G5E=0RD8((X->6^-_P!E_P"'GCQWFO=!BM+MO^7K3_\
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M7VH9-Q,.Y5#R3[MBOMSP/\!/ _P[*/HF@6T%PO\ R]2KYLQ/KO;)_*N^6 *
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MOL:#[BY]*^.OVEQGX[Z6/^F%K_Z-:OL:'[B_2MLO_P!YK^IMAOXM7U/(?VJ
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M?!'[9%M';_'_ $5XT"N\%H6;U(EXK[Y/W:^"OVSO^2]Z"?\ IA:?^C34\/\
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MHO,HXN^O+:QY)^TG\"1\9/"\)LGCM]>L"7M9)/N.#UC;V/KVKYH\/_%OXT?
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717BRQ\I2<N1:^1]+#*X1BH\\M/,__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>alt-20251106x424b5007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 alt-20251106x424b5007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" (' \L# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/Z]:W<W1K5GV3*>X*'G\JSJ86K37,U==UJOO1<:T)NR>OW';4445RFP4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW<MN$DS2$*WU"_I3K86@YU9+11\]TUI;Y_F%.M4Y8)ZN7YWU_ ^ZZ^*OCO\
MM%^.?"?QB\5Z!::Y'H1TN"WET+24LOM#:PS@94GJ,L2/PK[4;.T[>&QQFOS/
MUSP?J]GI_B&U\0>$/%US\;EUPWNFZ_86;302@$; LF<"/[QP.F1TQQCEE.G.
M<G42>VGJ]]>BZ^I>,E*,4HZ?U_5C]'/"E]?:IX8TF\U.V%GJ,]K'+<VX_P"6
M<A4%E_ YK5KY^_8YU;QE=^"M8L?'=KKD7B.UU!S/+JZ@(V[D+">ZCVXYZU]
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M ("/M*DQBOEWQA\8?'?BGXT^"O"_@S4K32-.\1^'?[1=[RW\PVY.]BX]2 H
M'3)KSNP^-?QGU3P%\0M3'B'2X#\/[V:VGF%GE]2*.P((Z* $/UW#TK2.7U))
M/F2O;\79=.Y+Q44[6?\ 6I]S8&>E+7RYXN^/_B_Q*GPN\,>%#::3XB\860O;
MC4+A-\=L@'S;5[G(-7/!/Q=\;^'/&?CWX>>+[RTU;6='T236-/UBUBV"1 F0
M'3U!9?R-9_4JBCS-J^]NMKVO]Y?UB%[?UM<]S^(NC6VN^"M6L[S6;WP]:O Q
MDU/3Y_)GMU')=7P<8Q7*?L]_#[P9X#\"*?!6H2:UI^I2M=2ZO<3B>6\D)P79
MP #W[5X?\*?%7Q.^*GP-U;QKXHUVQ?0)]'OH$TZ"WVRRNFY1*S=!R",#T%<#
M\._&?Q.^$W[-'A3QU8ZQILGA>RD6%M#-OEY(6D(+&3/WLYKL6#J*$J*J*_,E
M;HWKIMOIZ'.\1'F53EZ7\['W#)XVT*+Q9%X8?5+9=?E@-RFGEQYK1#JX7TJ[
MKFMZ?X:TF[U75+J*QT^TC,L]S,VU(T'4D]A7SX/'\]_^U]X>T];2R6RN_"QO
MS,ULIN5)YVB3KCVKR+Q+\0_B9\;?@)\1_'<6K:=9^$?]*LXM!>WRYME W-YF
M>'PV?J#6$,"YN-W9.U[^;:LON-)8E).RN]?P/L=_B?X4C_L/=KMDO]N?\@W,
MH_TO_<]:WH]3M);^6R2YB>\B0/) K@NBG."1U .#7QU:^++G0=*_9KL8;6QG
MCU!1'(]S;+)(@VGE&/*GW%6?V?M'\5C]KOXH/<^(89X+1XO[0C^S\W2$2")5
M/\.TX/O53P*C"4N:UDWZVE84<0VTK;M?E<^JO"7C;0O'=A-?>']4MM6M(9FM
MY)K5PZK(N,J2.XR/SK<KX>\$?M%ZIX!_9C\1^)8-/TZ+5G\32Z9:+:V@BA4D
M)\[(OWB!GZX KLO@O\=_&-S\1XO#6IWS>,;"_L'N(M0CTR2T^SW"C/E,6&"#
MV-*IE]2//*.RO^&_D.&*B^5/=_J?0OQ-^'&D?%?P7J/AK6HM]I=I\LJ@;X)!
M]V1/1E/Y\@\$UYE^SS\0M9T_4K_X6>.)-WBWP^@^RWK$XU.R'$<RD]6 P#W]
M>0U>&Z%^TOXY;Q?''XD\76OA'4UU,Q2Z%K6E/%:&WW$ )..=Q&.>E>\?M*^!
M=0NK#2?B'X67_BJ_"S?:8O+ZW5MUEA/J",D?CZUI["5%+#5FK2V?9_Y/9].O
M0CVBG^]IK5;^:_X![C17-?#GQWI_Q*\%Z7XBTQPUM>Q!RN>8W_B0^X.172UX
M\HN$G&6Z.]-25T%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBO%?V@OVA[+X4Z<^G:<T=WXDG3]W%G*VX/\;^_H*P
MK5H8>#J5'9(QK5H4(.I4=DC0^.'[0ND?""U%LB+J6NRKF.S#8$8[,Y[#VZFO
MD'Q/^U!\0?$MRT@UR73HB<K#8_NE7VXZ_C7FNMZW?>(M4N-1U&YDN[RX<O)+
M(<DDU1KX#%YG7Q,WRMQCV7ZGP>*S*MB)/E?+'LOU/6?"_P"U#\0?#5TDC:W+
MJ40/S0WW[P,/3GD?A7V#\$/V@-(^,%DT.U=/UR%<RV3-G</[R>H]NU?G+5[0
M]=O_  UJMOJ6F74EE>V[AXYHFPRG_/:GA,SKX::YFY1[/]!X7,JV'DN9\T>S
M_0_6*BO%/V?OVC+#XKV$>FZFT=CXGA7YX<X2Y _CC]_5>W;BO:Z^^HUZ>(@J
ME-W3/NJ-:&(@JE-W3"BBBMS<**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MWBS7;5K&^U'4$"2P1LA 5$' '0]^@KY\\7Z?+I?BG5;6=2LL=PX(;KUKVO\
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MM;H1Q]*^R?!WBR+Q3IPD&([A.)(\]/>O)Q-#ZO4Y+W(H5?;0YFK,Z&BLV_\
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M/"TW4J/3\SFQ&(IX:#J5'H6_VCOVE(/ %M-H'AZ9)_$,B[9)E.5M ?\ V?\
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M'JMNUI>L"\DDT)&#&7=BP7!Z BMB'X$> ;?3?".GQ^&;-+/PE,+C0X@6Q8R
M8W)S_/- 'SM^Q!J.O^&/C9^T!\+;_P 5:UXLT#PCJ5@VE7/B"Z-U=Q+<1.[H
M9#R1D+QTXS@9->5?%:6_^(/[4GQL\-:Q\9?$G@30]$T.'5-/T[2]7%HLEPL9
M(//.T'DJN,YYK[U\/?#7PSX4\5>(O$FD:/!8ZYXB>*35;V/.^[:-2L9;)QP"
M1QCK7S]J?[#GAOX@?M"^//&_Q!TG2O%&@:W;6J6%E,'$UO)%]YBRD<$=@>>]
M 'RM/^T!\3_B#\-OV=?#%_?Z[J$/B9+XZC-I&L1Z/>ZSY!984^V2$!,A0YP0
M7SCKBNG\7>.?C=\%OV7-=TW7M;U'05OO&UOI.EZS=:S!JFIZ5I$^&*RW,3$%
MUQM#GYOGXQQ7W-XQ_9\^'/C_ ,%Z;X3U[PCIM]X>TT*+&R\LQK:X&!Y;*0R<
M =#5;0OV:_AEX;^'>H^!;#P=IZ>%-1D,UYILH:5)Y" -[,Y+%OE7!SD8&* /
MD/3;[6/@G\?_ !/\/_"OQ'\1^,_"E[X%O-6N#K.JF_ET^Z2)BDJ3=4W=<"O&
M/!OCGQ7X:^'?P$^*&G?&GQ-XI\;:YXEM=%U#PU=ZH)K1[5Y-CQ&W'.Y1C+MD
MY;/!Q7Z':%^RU\/_ (<>"?%6C?#_ ,+Z?X:N]<T^:S>Z0.[L70JNYV+-M!/0
M'%<+^S-^PWX$^#'ASPG?ZSX8T;4?B%H\'EOKL"-\SY/SA2<;L'[V,^] 'R5X
MR^*GB?X1V?[9&M>$YY;'5I_'&F6)OH"%DM8Y=Z.ZL>%;!(#'H6![5[_^R+X>
M^*7ACXNW0OEURW^'&H:.LHM/$_BZVUVY^U@@^=$T;LRJX/(^[7TN/@=X#\OQ
MA&WA>PEC\7RB?78Y4+K?N 0&<$D9&3TQ67\*_P!FCX9_!/4[K4?!7A.UT.^N
M8_)EGCEED8IG.T;V;:,]AB@#Y8_; ^-?B#]F/]H#4]=EUO4#X<\6>";RUTVQ
M:X<P0:O$-L)C3HK'()(&26KR?X,_%'XE^)]?^%W[/6O^*-9C\<^'_&]U<^([
MR*]D,\^E00K<HLDN=S(YF90#QB-:_1KXC?!OP7\7/[(_X3#P[::]_9-Q]JL?
MM0/[B7CYA@C^Z.#QQ3=/^"_@C2OB7??$&T\-V4'C.^@%M<:PBGSI(PJJ ><?
M=11G&<"@#\R_CG)JWQ(^ 'QSN=>\4:]/'X>^(XBM(O[0?RDA,FW8RG(V*.5'
M !&:]!\:?!J'6_VC_P!G[P7HOQ"\46EC/X2O&EU^WU,3:D\99F>);@@[0<[<
M@9 &!7W1)\ ?A[-H'B;1)/"MC)I7B6Y:[U:U<,5NYFZNV3P?IBH/!_[.OPX\
M WGA^ZT#PK::=<Z!;RVNF2HSLUM%(2TBJ68YR23SGK0!XI_P3H\6>(]9^'OQ
M"\/>(O$%_P")_P#A$?&FH:#8ZCJLIENGMHA&4$CGECEFZ^N.@%?65<SX(^&W
MAGX<+K"^&M'@TA=7OY-4OA!G]_=28WRMDGDX'3CBNFH **** "BBB@ HHHH
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M)K=_:Q_Y-S\??]@N7^58MK!-<_"KX>1QPF7=IML,#N?+6NKH?47?M+>1Y/\
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M "BBB@ HHHH *^"?VTQ+_P +D/F9V?V?!Y>>FWYNGX[J^]J^:_VS/A3<^*-
ML_%.FPF:[TM3'=1H,LT!.0W_  $Y_!B>U>-F]*57"OEZ:GCYK2E5PKY>FI\1
MU[7^SY\3/ _PODFU36M*NK_7=VV"50I2),=5![GUKQ0@@X/!HKX&C6E0FJD-
MUW/A:-65":J1W1],^+_C'\,/&WBF3Q!J$'B4:@T8A0P7>Q(D'\*+T&>IQUJC
M;?$+X2RS*LLGBZ)">7%Z6Q^&:^=**]EYYC7;F:=O)'<\RK-W:7W'W1X&^&_P
MS^(UN9-"\3ZO=NHR\!U!EE3ZJ>?QZ5U?_#,OAK_H)ZY_X,&KX \-^)M3\(ZO
M;ZGI-Y+97D#!DDB;!_\ KCV-?HY\$/BE#\6_ =KK 58;^-C;WL"GA)1W'LP(
M8?7':OHLNS18Q^SG%*2\EJ?0Y?BJ.+?LYP2E^9A?\,R^&?\ H):Y_P"#!J\4
M\*(\.DM"\\MP8;B:(23-N<JLA R>_ K[(KXZ\.?\>5S_ -?MS_Z-:M\UL\)>
MWVET\I'7BZ<(<O*K'B'QYNM$D^./P[L_&TT,'@A+&\NB+TD6TMX.%5^V0N"
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _*W5O^1V\:_\
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M *ICKO\ X%VW_P 77S-10!],_P##P3_JF.N_^!=M_P#%T?\ #P3_ *ICKO\
MX%VW_P 77S-10!],_P##P3_JF.N_^!=M_P#%T?\ #P3_ *ICKO\ X%VW_P 7
M7S-10!],_P##P3_JF.N_^!=M_P#%T?\ #P3_ *ICKO\ X%VW_P 77S-10!],
M_P##P3_JF.N_^!=M_P#%T?\ #P3_ *ICKO\ X%VW_P 77S-10!],_P##P3_J
MF.N_^!=M_P#%T?\ #P3_ *ICKO\ X%VW_P 77S-10!],_P##P3_JF.N_^!=M
M_P#%T?\ #P3_ *ICKO\ X%VW_P 77S-10!],_P##P3_JF.N_^!=M_P#%T?\
M#P3_ *ICKO\ X%VW_P 77S-10!5M;ZYU?4M<U6ZL7TU]2U.XO5M975FC5VR
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M'Q;\*PZOI;F.53Y=U9R<2VTH^\C#MS7:5\_?$WX5:_\ #_Q5<?$;X9H#?O\
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M;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M $*]O_W^E_\ BZ/^&=?AU_T*]O\ ]_I?_BZ.;_#_ . /_P"6!]5J?W?N_P"
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ME6:)S)(VUU(*M@L1D$ UZ#1*2<4OR5E]W-+\SLH4I4T^:WR.-^,7_)+O$_\
MUXR?RK\PF^\?K7Z>_&+_ ))=XG_Z\9/Y5^83?>/UKX7/_P"+#T_4^7SW^+#T
M_4Z;X7?\E'\,_P#81@_]&"OU)K\MOA=_R4?PS_V$8/\ T8*_4FNO(/X=3U1U
M9%\%3U04445]4?4!1110 4444 ?DUH_W=2_["5Y_Z/>K]4-'^[J7_82O/_1[
MU?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D=
M%D1D=0Z,,%6&01Z4M% 'I/[/7[1%S^S]J$6AZ_-)=?#6ZDVI,V6?0Y&/7U-N
M2>?[G7IT_0:RO;?4;2&ZM9H[BVF021S1,&5U(R"".H(K\KW19$9'4.C JRL,
M@@]017I/[/'[1%U^SY?1:#K\LMY\-+B0+%,Q+R:$Y/YFV)/_ &S_ -WH ?H=
M14%C?6^IV<%W:3QW-K.@DBFB8,CJ1D$$=0:GH **** "BBB@ HHHH \2^*7[
M/L]_K[>-_AYJ?_"*>.HAN9U_X]-0Q_!.G3GINP?<'LOPO_:1MM:U<^$?'EE_
MPA7CR [)+&[.VWN_1X)#PP/89^A->V5R'Q(^$_A?XL:.=/\ $FEQ7JKDPW &
MV:!O[R..0?TKNC7C4BJ>(5TMGU7^:\G\FCFE3<7S4M/+H_\ )G7 YI:^;DT_
MXK_L]Y6P,GQ-\%1?=@E;&I6B>@/_ "T '^17H7P[_:,\$_$:3[);:E_9FKKQ
M)I>ICR)T/IANOX5,\+-+GI^]'NOU6Z'&M%OEEH_/^M3T^OS>^/NG2>#_ (L^
M+K!SY8FG%Y#VRCC/\\U^D (8 @Y!Z$5\E_MY?"JYU;P]:>-M*A+W.G+Y%ZJ#
M),)/#?@?YUX>.I>TI770^JR/%+#XKED]):?/H?"FIZBSO(2Q)R>:P3J+23")
M%,DC' 11DGZ"I;IY)-J0HT\\I"1Q1C+.Q.  /4GBON7]E/\ 87A\,0IXL^(<
M9N->N(\V^FHY4688=6(/W\=NW?GIX=##SK)\A]OF&80P<>:3UZ(^(]-\(^)_
M'&HKH>@^'-4U749L Q6UL6V ]V)P%'N2!7TC\9O@3XPOKGPE8:5X?N[W5-/L
MA;W5O#M>1%"K@G!(//H37Z&Z%X=TWPS9"TTRTCM(<Y(0<L?4GJ3[FI#HEDVK
M#4C IO0@02GJ!S_B:])9?[D>9Z]?^ ?(O/JCJ<_+MMZGY^?#+]BCQSXLU*%_
M$EJ/#&D*P,KW$BO.Z]PB*3@^[8_&OO?P=X0TOP'X<LM#T:V6UT^TC"1H.I]6
M)[D]2:VJ*]"AAJ=!>[N>1C<RKX]KVKT71;!117/>,/B#X<\ :>][X@UBTTN!
M!G,\@#'Z#J:[(Q<G:*NSRFTE=G0UQGQ,^+WA7X1Z,=0\2:I':A@?)M8_GN+A
MO[L<8Y)]^@[D5Y1=?'GQG\6IY-.^%/AN2.R)V/XFUJ,Q6\8_O1H>6/\ G!KI
MOAM^S7H_A;5QXF\3W<OC3QF^&?5=3&]86](4/" =CU';%=WU>%'7$.W]U;_/
MM^?D<WM95-*2^?3_ ()Q5AX+\:_M07<.K>.([CP?\/ PELO#$3E;J^7^%[EN
MJ@CG;^0'WC]%Z+HMAX=TNVTW3+6*RL;9!'%!"H544=@*O45A6KRJVBE:*V2V
M_P""_-FE.FH:[M]0HHHKF-@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /S>_:H_Y+AXC_ZZ)_Z M>2U
MZU^U1_R7#Q'_ -=$_P#0%KR6OU[!?[M2_P *_(_+\7_O%3U?YGZ)?L?_ /)"
M-&_Z[W/_ *.:O::\6_8__P"2$:-_UWN?_1S5[37YAC_][J_XG^9^AX+_ ':G
M_A7Y!1117 =H4444 %%%% !1110 4444 %?*?[=W_((\,_\ 7:3_ -!KZLKY
M3_;N_P"01X9_Z[2?^@UY.:_[G/Y?FCRLT_W2?R_,^.Z^H?V$?^1L\2?]>*_^
MC%KY>KZA_81_Y&SQ)_UXK_Z,6OC,K_WRGZ_HSX_+/][I_P!=#T3]L/QUK&DZ
M9X9\):'=OIUSXDO1:RW<9PR1Y .#[YKB_B-^S5\+? GA^WM)O%LOAGQ>\:S0
M:K=73EI&!Y8J.Q(->I?M1?!W5?B=X;TO4/#;(/$NA7(O+.-V"B;')3)XSP,9
MKQ;XE>,O%WQ;T#^P]4^ NH7/B_[*UFFJW4+&&W)!!DC<H .>1\^ >YK])/T4
MU_VF]4-W^S+X,EA\0IXD=-7@A;5[?*BX*+*I/UXP?<&O9;SXS-H?Q5\*^ _[
M.$HU.Q6?[87P4PO3'X5X=\0_@KXNT']D_P %^$AI,VIZ[9:PMQ<6VFH9S&K-
M,W.T=MZ@D<9[UU'QIT7Q/X1^,G@/Q[IOA?4?$NFV5F+6ZM],B,D\;8_N@$]^
MO3B@#TW3OCBEW\;-?\"3V"V]MI.GF_?4#)U4!2<CZ,?RKSY/VK_$>N66H>(O
M#?P]N]7\&6-R8'OQ)^^E (!9$')QGT-8?@+PCXM\9_M">-=;UWPO?^&M,U[P
M_):PR3IN$8=450SCC?C)*YR,&LCX<>(OBC\#? =Y\.[7X;:EJFN17DIT[5H8
MC)8,LC9W.X&,#)/)'4 XQ0![;XW^,^O6%KX>7PIX*U#7+S6(1/BX0PQVJX^[
M*3]UO;VK+^&G[3$/B:'QE%XFTG_A']0\*QF:^CCE$J%,'[I'4Y4C\J\\^-UA
M\0KOQ+X.D\3Z%K7B+PJ;$#5--\(EQFZ/4$*<[1QR3C@\BN9^&'P?UJ;5/B]I
MEWX7O?!&FZ]I:C3S?Y:&+!9E5YLD9Y7/.1SZ4 =U)^UUXCB\%WGC5_AY<CP@
M2R6E\)P68[MJLZ]E)XR.]=9XI_:=AT'P;X0O+31)=5\2^)XEDLM'@?GGJ2?2
MO!/$'B/XAZ+^R_J/@34/ LEC;:5!Y5QK\TZ_9GMQ+D>7CAW)(7Y6([UTU[X&
M\4V7AKX.?$?PSH[^(GT+3T2ZTN'_ %KQGG<@ZGOTR>G% 'KGP]_:&OM6\?)X
M*\:>&9?"?B"XB,UHK2!X[A0,D ^N ?R-<GI_[6'B3Q-_PD\/ASP#-JMQH%Q(
MMU()PL2Q+G!SU+G:W ["J>@:5XM^.OQ^\.^-M1\):AX-\.^'(&$0U5#'/<R$
M,,!2 <98G.,8'O5S]FGP7KOA[2OBTNIZ->Z?)?ZE+):BY@:,SKM?!3(^8<CI
MZT =;!\5;3XR?LXZYXDM+9K/S+2:&6W<YV2*!D9[CD?G7Y^-]X_6OL;X)>%]
M8\(?LC^);#6],NM)OM]U)]GO(C&^TJF#@\XX/Y5\<M]X_6OBL_\ XL/3]3XW
M/?XL/3]3IOA=_P E'\,_]A&#_P!&"OU)K\MOA=_R4?PS_P!A&#_T8*_4FNO(
M/X=3U1U9%\%3U04445]4?4!1110 4444 ?DUH_W=2_["5Y_Z/>K]4-'^[J7_
M &$KS_T>]7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M$8I/+Z23?MX_U\QK%3;M[-GV#7RG^WK_ ,B]X9_Z^9/_ $&OJL=*^5/V]?\
MD7O#/_7S)_Z#4Y1_OU/Y_DS+-/\ <Y_+\T?&%?3O[!O_ "/^O_\ 8,/_ *-C
MKYBKZ=_8-_Y'_7_^P8?_ $;'7WN:_P"Y5?3]4?&9;_O=/U/MZBBBORH_2 HH
MHH **** "BBB@ HHHH **** .-^,7_)+O$__ %XR?RK\PF^\?K7Z??&(9^%W
MB?'_ #XR?RK\P6^\?K7Q6?\ \6'I^I\;GO\ %AZ?J=-\+O\ DH_AG_L(P?\
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MY)- !\-OAOH/PH\(V7ASPY9+9Z=:K]7E<_>D=NK,QY)-=1110 4444 %%%%
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MW^RUXE^+>E_"#6[?P;X5T?5] ;4;LR7=[>&*4.47>-H'0#'YU[?_ ,$_"[?
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M+U6R@D)P$/H<\8-"HU&DU%ZZ;![2"TN=U17-ZM\1/#NAZWHVD7NJ0PZCK/\
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M?@'+_P )_P"*/$[?$KPQ<ZAXBBUS4#-!-/Y E4QQ !8PI8!54<!0!U.?2?\
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MT_5+-_*NK*?[\+_U!ZAAP1R*\:FEBYOF?+)--QMU75>1]!*7LHIQUB]GY/\
M4\Z_9\TF?2OAAI[W43P7E[+->2I*I5@SN3R#S7@^K'6=%UJYU&UT?69?B;9:
MK/<>=]E:6WFM"" -W3:%Z 5]?$Y//-+N.,9./2NJI@U.G"FI6Y?ZOZF4:_+*
M4FMSF/"^J7TGPXTW4=1,TVHMIJSS^;#Y<C2;,G*#H<]J^3]-TG1-6\#W%M_P
MA_B"[\>W<SR17:VLB1H[/E22>, >HK[6SS2EV/5C^=.OA/;J*<ME;:^]M?70
M5.O[.]EN>*^%/#=WK/QGMYM>MC<-H.@6]N)I8_W9N'Y<J2,$CGI7G&OW&O\
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M\1O#FEZMIOQ(\/2&[M_!%M/+:/<V<0"*5EY$C(I7!."9/K7*_!"QTNP_:O\
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M[PPEU92PZ'\0M-BZ'I(.X/\ >C/YK7C\\-WINHW>EZG:OI^K6;;+BUDZJ>S
M]U/4$=:X*%=U&Z=1<LUNOU7D>U."24X.\7L_ZZA111788A356>YN[:RLK>2]
MU&[?R[:UA&7D;^@'<]!0BW-Y?VFG:?:R:AJMZ_EVMG%]Z1NY)_A4=2QX KZ!
MT30/#O[+_@^?Q1XIN8M1\57:;-R=<XR(( >B#NW?J>PKAQ.)5!*,5>;V7]=#
MHI4N>\I.T5NP\->&= _9L\*3>+/%MQ%=^)IX]HV<[,](81Z>K=Z^0_BY\7=9
M^+?B*34-1E*6J$K;6BGY(4] /7U-0?%3XK:S\6/$<NIZI,1$"1;VJG]W"G8
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M3JUF^FZS9MMN;.0YV^C(?XD;J&'44D<=U?7]KINFVCZAJMX_EVUI%U<^I/\
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MRWK8=:=5_D?)=E>SZ==17-M*\$\3!DD0X*D="#6IXL\::UXXU$7VMW\M_<A
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBO+/CG\>M,^
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %;4=-M-6LY+2
M]MHKNVD&UX9D#*P]P:\0\0?LIZ=9:D^L?#[7+[P%JQ.XI8N6M9#U^:(\?E7O
M%%;TJ]2C\#M^7W&<Z<*GQ(^=D\>_&WX9 )XE\)VGCK38\ ZAH4GEW&/4QG^0
M!K9T/]L/X>WUPEGK-Q?>%-0/!M=:LWA(/UP?S.*]PK*UOPIHOB2!H=6TFRU*
M)N"EU L@/YBNCVU"I_$IV\XNWX.Z_(R]G4C\$OOU*>A_$+POXFC5]*\0Z9J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M3#$88$$8;&#UQ0!U-%>=Z1\<?#UVMRNIM_8EQ#-' ([B:*99G=2RB-XF=6.
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MXQG<HPPPS* W8FI?&?Q+7PEK=MI4.C7NKWDMG+?D6TD,:I%&0&),CKD\\ 4
M=I17DEI^TOX8OO#?BK6H+/4WMO#YMA)'Y*B2Y\^-'C,(+<_ZP*<XP5/;FM"7
MXWVDVLMI6F:#J>JWJ2W,;I$84 $ 0NP+R#.?,& .3S0!Z716)X;\8:;XKTB'
M4=.>22&2$3;#&0X!SP1ZY!&!W%<BGQJAF%W!#X9UJ75+>>.)M/5(MZJ\;RAY
M'\SRXL)&Q(=@P)48RZY /2:*\VE^/WA=&TD1K?SG4M)?6HQ%;%O+@50V'YX8
MYX'.<'L,U2/Q_M)= .K6OAW4KN)+N.QDACFMP_FN5"*F9-LA.X'Y2<8.<8H
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M(L.R^;YNTGC]*PB_Q+TVYFT^TM-5MX)=3ED^5=RSQS7L_FMG.%PA4Y/0$8%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "F21)-&R2*'1A@JPR"*** '*H10J@  8 ':EHHH **** "BBB@
M II12X?:-X& V.0*** '4W8N_?M&_&-V.<444 .HHHH **** &-#&\B.R*SI
MG:Q'*YZXI]%% !5:\TVTU#R_M5M%<>6=R>:@;:?49HHH ?!:06K2-#"D1D;<
MY10-Q]3ZU-110 4C*'4JP!!&"#WHHH %4*H   '  [4$9&#R*** (Q;0B P"
M)!"1M\O:-N/3%2*H50   . !VHHH 6BBB@ HHHH **** "BBB@ HHHH ****
M &>3'YWF[%\W;MWXYQZ9I]%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>alt-20251106x424b5008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 alt-20251106x424b5008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 'T \L# 2(  A$! Q$!_\0
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MSUYJQX\^*6C?#N6TCU6.\=KI6:/[+!Y@P,9SSQUKL**.2M[/EYUS=[:?=?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\2!X4O?!OC:77M(UC4I]+NKJ\TZ2VDLIH86G?]WO8NIC0E2",DJ#@G U;?\
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MBKJ5_)V\CZ_^%G[3?PX^,+00>'O$=N=3E7(TR\/D76>X"-]XC_9S7J=?C/\
M$;X96O@CPWX'U:;49(=?U^Q.K?8XH?+-G"7Q _F!CN+@%A@ @ >M>H? W]O'
MQO\ "6[M]-\823>,_"OW#)*V;VW''S+(?O@#^%OP([^97RI\O/AW==CT:.9I
MRY*ZLS]2**Y#X7_%GPM\8_"\.O>$]6AU.Q?B15.)8'[I*AY1AZ'KU&00:Z^O
M :<79[GMIIJZ"BBBD,**** "BBB@ HHHH **BN;F&RMY)[B5(((U+/+*P55
MZDD\ 5\>_&7]M^?4+N?P[\*+=+^Z5C'/X@N8\P1@9!\I3C<>GSMQCL<Y'7A\
M+5Q4N6FO\D<U?$4\/'FJ.Q]3>-?B#X<^'.E'4O$NLVFCVG(5[F0*9".R+U8^
MP!KYP\;?\%!/#MJYM?!'AS4?%=WG'GS#[+;CW!PS-]-H^M?(VJ2IKOB>W?Q-
MJM[XU\5WTXBAMC*7#2.W"+DX W'&!@#VKUW7_P!GKQE'9WFFZ#XH\'1^*;6W
M,\GA2QOE-^ !DKCUQW.!R.>]?1PRW"8:WUF5W]R_S^>AX,\QQ->_U>%E^)<U
MK]L+XT:R2UGINA^&X3TW1%VQ]78_RKC+_P#:6^-S,S?\+ L[?/\ #%:6V!^<
M9KSGQ?\ !;XB6WAGPWKD,.I^(H=9L'U&2/3+.>5K%%;:1-M7"]_;@UYWI?@K
MQ7XATB[U;3=!UC4M+M,_:;ZULY98(<#)WNJE5P.>37JPH8.UXPC;T7ZGESQ&
M,O:4F?0<7[6'QPL2,>,+"]P<XELX.?;A172Z-_P4%^*.@M&=:\-:-KD"_P"L
M,&^!V^C D#_ODU\N6?@#QC>^'7U^U\-ZY<:$@+-JD-A,UJH!P290NT8/7FO2
M_!G[.?C'QF^G_P!A74]R+C0VUN5IM.NX5C4 ;8D9X@)G<G"F,LIP<$XJ*M#!
M6]^*_KT+I8C&7]V3?]>9]D?#[_@HA\-?%<T-IKT6H>#KY^&-_&)+8'T$J<_B
MRKTKZ4T#Q#I?BK2;?5-&U"VU33KA=T5U:2K)&X]F!Q7XS7?@GQ=)KL&@7_A#
M6/[:N8_-ATY]-F6ZD3GYECV[B.#R!V-,\!?$OQE\&]7:^\%Z]=:1()-TUBQW
M0RD<$21-\IZ8Y&:\JOE%.2O0E\MSTJ.:SB[5X_,_:VBOE']FW]O;PU\6)K+P
M[XN6'PIXOD C7>V+.]?_ *9N?N,W9&/L"QKZNKYJK2G1ER5%9GT5.I"K'F@[
MH****Q- HHHH \P^#6D7VEZY\09+RSGM4NM>GF@::,H)4+-AESU'N*]/K&T#
MQ;IGB>YU2#3YVFETRY:SN@49=DJD@CD<].HK9KFPT(TZ2C!W6NOS,J45&"47
M=!11172:A117F/QL_:$\*? S2DFUJX:YU.X!^R:5:_-/.0/3^%>@W'CTS6E.
MG.K)0@KMD3G&G%RD[(].KQ3XA_MA?#'X=W$UI/K3:UJ,1PUGHR?:'W>F[(0'
M_@5?'7Q.^./CWXS">?Q#J_\ PB'A%G)BTFQ<HSIR )&SND.#SGY2>@%>/W'C
M[0/#*&'P_I:32C@W5R-Q/O7U&'R56YL1+Y+_ #/G*^<:VH+YL^K]<_;R\<:Z
M\@\*> ;:QM"<)<:I.TKD=B0NT ^W/UK@M6_:A^.-YDOXETC1\_P6]K$2/^^@
MU?,NK?$;7M78^9>O&G9(N *P9;^YG),D\CD^K&O9A@<+3TC37SU_,\B>.Q,]
MYOY:'TTW[3OQNMI2P^(%M-_L-9VV/TCK0TW]M7XUZ))NGN]&UR+^[-:JI_-"
M*^4/.D!SO;/UJ2.]N(ONS./QJY83#RWIK[D0L9B([5&?>/@S_@I4]I.MOX[\
M$S6R< WNB2[\?6*0CCIR'_"OICX6_M)_#OXQ&*'PWXDMIM1D3?\ V9<GR;H8
MZCRVY..^W-?D#'KUTJ['?S5]'&:@<P3S1W$1:SO(V#QS0DJRL#D$$="#WKS*
M^44)ZT_=?X'HT<VJPTJ*Z/W3HK\OO@7^WOXS^%=Y!IGCAIO&/A<_)]I8_P"G
M6PS]Y7/^L&/X6YZ888P?T6^&OQ1\,?%WPO;^(/"NJPZKITPP2AP\+]TD0\HP
M]#_+FOE\3A*N%=IK3N?28?$T\0KP9U=%%%<1UA1110 4444 %%%% !114-Y>
M6^G6LMS=3QVUM$I>2:9PB(HZDD\ 4 35S?CGXC>&OAKI0U'Q-K-IH]JV0AN)
M,-(1U"+U8\CH#UKY6^,/[;]WKEQ/X?\ A-;BXD#%)O$5U&?*0<@^4C8YZ?.W
M&.W.1\K>)]9TZ/5)-4\8:S=>+?$$A+/YLI=0<YQ[#/8<5]#A<GJ54IUGRKMU
M_P"!_6AX>)S6G2?+27,_P/L/QI_P4%T&"0VO@?PSJ/BFYSC[3<?Z+;CW'#,W
MT(7ZUYCK7[8'QIU@EK2PT/PW">QB+M_X^QKY@U3XO:C(C0Z9!#IEOT A7!Q]
M:Y.\\1:G?L3/>S2$^K&OH*>782DM(7]=?^ >%4S'$U/M6]#Z8O\ ]I;XW%F;
M_A8-I;Y_ABM+; _.,U##^UE\<+$C'B[3[[!SB6S@^;VX45\OM/(W61C]2:!<
M2KTD8?C70\+AW_R[7W(YUB\0O^7C^\^Q]&_X*$?$[060ZYX8T?7(%^^;<O;N
MWT8%@/\ ODU[G\/O^"AGPR\6RQ6NMB_\'7S##?VE&'M\^@E0GCW95K\S8=7N
MX#E9W_$YJ274UO5VW4*2 ]\<UQ5<KPU1:1L_([*69XBG\3NO,_<#1-=T[Q+I
M=OJ6DW]MJ>GW"[X;JTE62.0>H920:O5^*?P[^*OC+X.:E_:'@CQ!<:<I??+8
MN=]O,>GSQGY3QWZ^]?H/^S9^W?X8^,4UGX>\3)%X5\9.H00R-BTO'[^2[?=)
MZA&.>P+5\UBLMJX?WHZQ/HL-CZ6(TV9]2T445Y!Z84444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %<9;>![J'XN77BTW$)LYM)&GB
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M6N>.-)T#3[*SO%@&D7EUIVLV"LVX6H@4O'<HV-N6_A/ SS3_  ;\7_"-K<^
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MZQX<;5+1[9"LU]IOF+Y2D9(9TZ# [GM5VT\0^-[*>Y\5VVH:[#+/\D^M12S
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MJML)&C!YAE!*RQ'W2177_@-?B;J$ GMF!':OM/\ X)3?%*2*[\8_#2\G_=Q
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MX=^'8K:T11J,Z?,_=1_C7-33O<2M)(Q=V.237OT:$:*\SPJ]=UG9?"=#K_Q
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M,^<F2)6/U(K[,_X)%1.=>^+<W/E%=-0?4&Y)_F*^(=+F\OP?9$\?N17Z"_\
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M"5.[(QCKQS5OX@>$='\-IXSUW3_!EIXRU6;Q(FFO:7*R2_9H#"I^0*VX,Q.
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M[>)"^U<9DSN R3GK]*\@@E\F>.3&=C!L>N#78:QXWTKQ'XNU/5]4T%KFWO$
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M=E"/8J01[&L6^.+20^@K["_X*<?"(:'XQT7XC:?!LAU519ZBR]YXU C8^YC
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M6K;ZW=ON/2[7]F[P?'XAU*UGUN^O%ET^UU/2=+2\MK2\GBE)#!GE4QEDVGH
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M?LN>!M.N;<VU_>6G]J74;*5827!,@# \A@K("/45[U3(HTAC2.-0B( JJHP
M!T%/K\]D^9ML^\2LK(****D97U"RCU*PN;27_57$31/]&!!_G7X9>,O"EU\.
MOB-XD\+WL9BN-,OYK8AEV[@KD!A[$8(/<$&OW5K\T?\ @IG\)W\.?$72?B#9
MP$6FM1+;7DB]!<1*%7/UC"_]\'TKVLJK>SK<KZGDYE1]I1NNA\GT5';RB:)6
M!S4E?<'Q85T_P\\.CQ!KR>8/]'@(+9Z$_P#UJY@G )/05Z3\-S]@T S@8EGY
M_/FNO"P4ZJOT.;$3<*3:]#TKQ#<:G-H0DL[.XB\/6\PM?M:1D0M+M)V%^F[
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MG5I-R<KW2LK.][V_(\!T.P^)/A;59-#T:W\5:1J4R?:'TVQ2Y@F=1QO,:X)
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MV_:3/7K2UAL;6&VMXUB@A18XXT& J@8 'L *EHHKY ^I"BBB@ HHHH ****
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MBC"JJC@ #L*M@8&!P*6ODZU:5:5Y'T]*E&DK1"BBBN<V"BBB@ HHHH ****
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MOFI2<WS2W/H(Q459!1114E!1110 4444 %%%% !1110 4444 %%%% !1110
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M$_LT_#'X>E6T3P9IL,R_\O%PAN9?KOE+'\J]-HK*>)K3TE)FL:-.'PQ$50@
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M[$2WG^1"PM&.T3S;P5^S?\,_AZ5;0_!FF6\R@8N)HC<2\?[<A9OUKTA5"@
M #L*6BN24Y3=Y.YT**CHD%%%%04%%%% !1110 4444 %%%% !1110 4444 <
MSXJ^&7A/QQ"\6O>'=.U16SEKBW4MSWW8R#[YKQWQ-^PE\+]>#_9+6_T4$?+%
M:7/F1*?7;*'/Y$5]$45O3KU:7P2:,ITJ<_BC<^.+O_@FGX4ED+6_BK4K4$\
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M,>U<U?V?N>T[JWJ95.7W>;OIZG;4445TFH4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'OP.N!)X/UZ6YT@$%M"U%VFLR.,[4)_=D@8RA%=4,>E+DJJS/!Q'"E2=%8G
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M?XS XC 5/9XB-G^#]&;5%%%:G %%%% !1110 4444 %%%-=UB1G=@B*,EF.
M!ZF@!U4]6UFPT&QDO=2O;>PM(QEY[F01H/Q-?./Q6_;%MK2ZGT#X=6@\0ZR#
MY;ZDZG[) >^.\AZ^B^YZ5\U^,]4N-?OEU7XC>*+C6KU<^78K)^[BSU54'RKT
M&<#G'->96Q].E[L=7^!]OEG"F+QJ56N_9P??=^B_SL?6WC/]L[X?>&93;:9+
M>^*KP9!32(<QJ>.LCE1CG^'=TKS?4?VU/&.I,3H7P_BMX3T>_N6=O_'0HKYZ
ML_$^I76FWUSX/\(7,NGV*[KF^@LWF6!<$YD900HP">2.AKG;_5_'6J: ^O/:
MZH-"5_+.HQVL@M5;.-OF8VYR0,9[UYD\;B);:?(^ZP_#.48?2:YWMK+KZ*Q]
M"77[6?QB!)32?#D(]'@D;_VJ*B3]LSXKV; W'A[0;E1U6-)$)_\ 'S7S-J%M
MXFM-)M-5O;;4[?3+PD6U[-"Z0SD=0CD8;'L:M6?ASQG>:"^NVNCZU<:+$K,^
MI16<KVRA>&)D"[0!@YYXK%8G$7^)G?+)<GY=:,;;;]>V^Y]6:5_P4&N[&5%\
M1^ 9TBX\R73;L,R^I".!GZ;A]:]H\!?M;_##X@R1P6OB%-+OGQ_H>KH;5P3C
MC<WR$\_PL:_.2>[U_3M.LK^\M;F/3K[?]EN+B!EBN-A ?8Q&&VD@'&<9&:@\
M1:7)8WLEAKVC3Z5?H 6@N8&AE4$9!*L 1D$&NB&/K1^+4\C$\*9;77[AN#UV
M=]M]'?8_8..1945T8.C#(93D$>HIU?E#\,/CMX\^"$X/AO5VU'1<@R:-J+-+
M 0,?<&<QG QE<?C7W3\ _P!KKPA\</)TQF_X1[Q:5)?1;R0$R$#YC"^ )!WQ
M@-C/'&:]>ABJ=;1:,_.\SR#%Y;>4ES0[K]5T/=:***[3YH**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2M_ I@^)]SXN^UY$VF#
M3_LNSI^\5]V[/^SC&*ZVN'M?&E_-\9;OPJR0_P!G1:.+]6"GS/,\U5QG.,88
M]JYJ[IKD]IW5O4RJ<ON\W?\ $[BBBBNDU"BBB@""^OK;3+.>[O+B*UM($,DL
M\SA$C4#)9F/  '<U\&_&[]HK6/CSJEYX?\)WLNC?#J /%=W^TQRZJ.A.3RL6
M,X7@MG+=@'_M7_':;XN>*KGX>>'+N6'PGI4P&L7L3;4OYEY,0(Y,2'KV9QW"
M@GY_\2>)E%NNE:8/)L8N#MXWGU->+C<6XOV5-Z]6?IG#7#L:T5CL9&\?LQ[^
M;\NRZ^AKZAXTL?"MC_9/AF!(50;7NL?,WTK@[N\FO9FFN)6ED/)9SFLS4]7@
MTQ1YA+RM]R).6:I;'PGJ.NVXO=;NUT72NHCSAG'\S_*O(A2<]7HC]$Q./IX=
M^SBN:79=/5]/S\CIO#/QRO/AOX?\0Z)IC0/_ &X;8S2(CO<0M [/&T95@%.6
M_B!Z#&*['5/VM/B'XSU/6[UO"NFWRZNVGF>&>"58E6SF$T:*/,R%9@=X).0Q
MP5[>5OXN\+^$P8M$TM;V=>/M-P,C/KBL/4OBEKNH9"W MD_NPKM KNC[BY5_
M7]7/E:]L14=2:2;[+7IU=_Y5VV/8[3]H3XSV/CZY\5N(+E[EYFDTF]DGDL"L
MBE3'Y7FCY0#P,\8'-7/#W[6OQ0\&Z+8V#>$O"FJ/IL?DV%_?:>\MU9QC.Q(Y
M/,Z)GY=P/OFOG27Q)JDY.^^F;/\ M4Q==U!2#]KEX]6K55)+8XYX2C4^)=OP
MO;\V>I>+_P!I3Q)XK\(V/A[Q'I:F"UOY]1^VQ(3/)-,27WG<%QDG "C%3^-/
MC6WQFUFTU*\:R@N[6RAL%AMD>+Y(P0I*NQ)//)!Q7E@\27; B8K.IZAQFJ5W
M!8ZGRT0MY>S)6,HJ:LST*%:>&DI12=K[JV^]FMK^C/258J>#BJ&JZ7%J:!B-
MDR$.DJ'#*PY!!'0CUKA;/Q+JGAG"39U.Q'3<WSJ/9N_T-=UI.LV>N6OGV<PE
M3HPZ%3Z$=C7'*G*E[RV[GT=#&4,<G2FK/K%_IT:_IV/K?]DC]MF\T_4-/^'W
MQ.O&G\U_(TSQ-<,,DG[D-R?7LLG?@-ZU][U^)6N:3%J5JR.H;BOM3]@;]J6?
M6_+^%'C.]FGUNUC)T/4;@[C=VZ#)@=B<F1 ,@GJHZY7GW<'BO:KDGN?E?$60
M_4)?6,.OW;W7;_@'W#1117IGPP4444 %%%% !7C/[1?[1VF_!'1X[.S2+5_&
M5^I&GZ3DD#MYTV/NQ@XXR"QX7HQ7<^/WQLTWX%^ ;C6[M?M>I3-]GTW3U/S7
M4YZ#V5?O,>P'J0#^==UX@OSJ&H>+_$UV^J>*M5<S-)+_  9Z!1T55& JC@ "
MO.Q>*]@N6/Q,^QX>R)YI4]K6TI1W\WV7ZFQK.J7$VK/XM\?:B_B'Q1.@")+C
M$2Y)"*HX102<*/6N&\2^-]2\22$2RF*V'"P1\*!6-J6I3:E<R7-S(7=N26/2
ML)-1N]8O!9Z+;F[F)P9<?(O^-?.6E4=WJS]H<J.#IJ$4HQ6R1I22I"I:1U11
MW8X%>V>(/VXKW4H/'5G::/B+Q,8/W<,QD%H418Y=IV#?YB(%[8QWKQ63PEHV
MAJ+GQ5JIN[L\BT@;./;T'X55G^)]CI8,6B:+;P(.!+*H9OUKLIQE33L]SYW&
M5J.*:<Z:=MK^J?YI=_S/:_%'[8WC'6!K]SX7\+W7A?4]9OK>[N=0M[HO)Y4-
MJD"PC,8X)3?N'/..G6C+^U=XBOKCPW>>)OA[:^*+W3K.XTZ^N-3E$AU&WD8,
M P,?[MT(^5P2>3D<UX/>?$W7KML_:O+']U!@50;QGK#DEKQSGUKHYI=7_6YY
M"H44DHQM;[]K;[[>?XGTN?VYGT/5O#"Z5\-;?PYH&B7<E\=*M+DMY\SQO'DN
M4&T /G 4Y(ZUPW@K]H:PTG2_'M@EK&S^+8/(83S&)K;YV?(!7#_>QU'2O(/^
M$MOV&)628?[:YJK=7%AJ8/GVJQL?XDXJ)7EK?^MC:BJ=%-*":=KWO=V?,M;]
M]3OP00"#D>HI7/FH4<;E/8UYM#/J.@L)=/NFN+<=;>4[EQ[#M^%=3X=\96FN
MMY#@VE\.L$A^][J>_P#.N&=*4-5JCZFACZ5=\DM'V?Z,[?X7_%?Q5^SYXL37
MO"MPTEC(X.H:-*Y^SWJ="&'\+8Z..0?4<5^HWP,^.'A[X]^![?Q%H,AC8'R[
MS3YB/.LYN\;@?F#T(Y%?D_)&)%(/-6?AC\5->_9X^(EKXN\/F2:VR(]3TP/B
M.^M\_,A'3<.JMV/MFO0PF+<'R3V/D>(<@CB8/$X96FM_/_@G[-45SOP\\?:-
M\4?!>D^*O#]R;K2-3A$T#L-K#G#*P[,K J1V(-=%7T)^/M-.S"BBB@04444
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M^'-]Z/L_XL> M)\2_"?7? FB^(-$U:[\,V<$^EZ7:7"-?1/;H1<^:@.<OSP
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MD\3AU[CW7;_@'V#1117JGP84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 5RD'@00?$VY\7_;=QFTT:=]C\KI^\5]^_=_LXQCOUKJZX6U\:
M:A-\9[SPLRP_V9%HXOU8(?,\SS57KG&,,>,5S5W37)[1=5;U,JG+[O-W_$[J
MBBBNDU"OG_\ ;.^-=U\)?AFECHMR+?Q1XBD:RL7&"\,8 \Z8#U56 ![%UKZ
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M++)_*N]$U*WU!&_ZYR*S ^H*Y!'<&OW$L;M-0LK>ZC_U<\:R+]",C^=?AO\
M$*T%QI4P(SN0C]*_7G]E+Q1_PF7[-7PRU9F+RR:!9Q3,3G=+'$L4A_[[1J[<
MOE>FX]CYKC"@J>+A47VE^7_#GJU%%%>J?!!7YU?M]^-I?$OQZT3PPDF[3_#F
MFB=T _Y>;AMSY]<1QPX],MZFOT5K\D_CYK)UW]H_XCWN20FI-:KDYP(E6/\
MFIKS\=+EHM=S[#A6@JN91D_LIO\ 0\\\5ZU_9NGSW.<RGY(AZL>G^/X5RMK)
M_8NBE0V;NZ^9V[X-/\9W'VW7K&RSE(E\Y^>YX'Z#]:S;ZY-S.3_". /:O&I1
MY8W[GZ/CZSJ5G'I'3_,KDY.3UHHHK8\T**]__9(T/1K^[\>ZGK.G:8Z:7H+S
MVVKZ]:BZT[3IBZJK30D'>6Y"@!CD'"GM[-\1/"?A;X?K\2O'.E^$M!O+O3M"
MT&:Q\ZPCETNX>[E9)KN"V.55&"84$?*0>.:WC2<H\USS:N-5.JZ7+=Z?>[?Y
M_P# /AJBOJ+X]_LR:QK'Q)U/5O OAC'AM=+LM6U&&Q>***P,D.^141V!Q\C.
M ,XSCT%>W^,?@7X1\5^"_$UK9Z#X=TSP?';:3<>%_$&F+"+R;>X2Y9Y0=\@S
M(H^?(!8?@U1DVT9RS*C%0?\ -^&WXZ_<FS\[J*^X/B)H_@BW7XI6][X)TBST
M7X<:YHGV3[!8I#=7%L]PD=Q'+(,&4.FXC>3R>M<QK$7@KQ=IUUXS\+^%X]8N
MK6RFT+3+*ST%8DU+5)Y)71A:HI#?9[7<2=O+!#G(&1TK=1QQ_,K\C_X=)K\T
M?(U%6=3TN]T34;FPU&TGL+ZV<Q3VMU$T<L3@X*LK %2/0U6KG/53OJAKJ'4@
M]ZYUKY_"FOVNK1J2D38F1>K1G[P_+D>XKI*RM?M!/:OQU%4NS,ZB=N:.C6J]
M3U+4A'J.EB6,AXY$#*P[@C(-?9'_  2L\82S^$?'O@Z1BT6DZE'?P+_=2X0A
MA_WW"Q_$U\'_  MU<ZMX.>TE),]A(UNV>Z]4/Y$#\#7T9_P3AU]M"_:MU32B
MV(-9\.W"!.F98IH9%/X)YOYT\%>G6<&1Q+RXS+(8E>3_ $:/U/HHHKZ _(0K
MS[]H'Q^?A=\%?&7B>-PEU8Z;*;4D9'VAQLA&.X\QDKT&OEO_ (*,:P;']G^*
MP#$'4M8M8#@]54M(1_XX*F4N6+EV-Z%/VU6%)?::7WL_/[18VL="@B+%G<9=
MF.2Q]2:SO$^L'1M+>2,C[1(?+A'7YCWQ[=:U8S^YB4=%4"N%\1W']H^+8[=C
MF"R0$C_:/)_3%?(TH^TG>7J?T+C:OU7"J%/1NT5Y?\,D[$]M+_PCFB"*,_Z;
M<?-(_<"L,DL22<DU8O[HW=RTAZ=!]*KUW;GS"2BDEL@HHHI %%%% !1110 4
M444 )6#XBTWSH2Z%D=>5=3@J>Q!]:WZBN8Q+"P-4G9W,ZD%4BXL[3P-XD_X2
MCP_'<2%?M<9,-PHXPX[X]Q@_C3;'Q1+\,OB;X3\80-L?1M4@NG8?\\PX$@_%
M"PK@OAO?G2/&\MB6(AU"(X7MYB98?^.[ORKK/B19K<Z3.I&=R$?I7.E[&NFM
MMSUG)YCE4X5-9).+]5U^:LS]U**\O_9=\42^,_V<?AGK-PYDNKKP]8F=S_%*
ML*K(?Q96KU"OJ3\(/.OA/X7U/P[K/CF;4+8V\>HZW-=6S%@?,B9B0W!XZ]Z]
M%KG/"?CBR\7WFN6UI%-&^D7KV,QE  9U)!*X/3BNCKFPT80I)4W=:_F94E%0
M2B[H_.']N_QLOBK]HBR\/PR%[7PQID:RIV%S.?-;Z_N_(_,UX!/*9968G/-=
M!\6]7.O_ !\^).JY+>=K,\:DG)"QD1*/R05SE?.XR7-7D?T)P[0]AEE)=U?[
M]3-\0:N-&TYY@-\K'9$A[L>G^-96GW'_  BVFM>2'S=5O 6WMU4'O6=?W*ZS
MXM(<[K2Q!4#MN_B_7 _"J6IWSW]TTC'@<*/05K3AR1MU9P8K$/$5G+[,=%^K
M^?Y>I!<7$EU,TLK%W8Y)-1T459R!1110 4444 %%%% ",NX$5@W;W6@ZC%J=
MB=L\)R5[.O=3[&M^JU] )X&!':J3L9U(\RT=GT?8]*T+68/$&DVU_;_ZN9<[
M3U4]"I]P<BF:[;"XL7!&>*\Z^%FJG2O$%WHTC?N;L&> $]'4?,!]1S_P&O4;
MM-]O(/:O/JP]G.RV/KL#B?KF&YI?%L_5?Y[_ #/LG_@EAXWDU+X:^,_!\S;F
M\/:LMQ"/[L%TI8#_ +^13?G7V[7Y<?\ !-76WT;]I_Q'I6[$&K>'I&*>LD,\
M;*?P5Y/SK]1Z^JH2YJ<6?@F:4?88VK37?\]0HHHK<\L\Z_:'\;CX=?!/QCKP
MD\J:WT]X[=L9_?28BB_\?=:_*/3\V^D0QY.Y_F8GJ:^]_P#@HSK9L?@AIVFJ
M2#J6LP(PSU1%=R/S"_E7P2#^[C7L% KY[,97FH]C]?X,H*.&J5NLG^"_IA11
M17D'Z(%%%5+B\;STMK:,SW3\*BTTFW9$3G&FN:3LB>6>.!2TC!0/6DM$O]5.
M-.L)KH?WPN%_,U8E31O"2"XUIQJFIGYEM%/R1GW]:Y[6OBIK&I*8;:1=/M!P
ML, VC%=4:*ZGA5LR=[4T=#/X:UZ,9D>RM3_=>4$UF7%EK-O]VYLY?]UA7#SZ
MC=7+%I;B5R>Y8U$)Y!TD8?C6WLX]CSWC*[?Q'5S:[J.G'_2['<G=HSD5?TWQ
M%9:F0L<H27O&_!KC8M5N8L@2E@>S<U6O%BO1O9?+F'1TXJ'1B]C:GF-:#][5
M'IU%>>Z'XVGTJX6UU0F6W/"S]U^OJ*] CD66-71@Z,,AE.017+.#@]3W\/B:
M>)C>&_5#J0C((I:*S.LR?"?C1OA+\9/!GC%6*1:5JL,ESCO;LVR8?C&S_C@U
M^VU?A1\2K03Z5.",Y0_RK]F_@+XA;Q7\$_ FKR-OEN]$LY)&)ZOY*AC^8-?1
MY?*]-H_&.+Z"IXN-1=4=Y17G_P =_BS;?!+X7:SXMN+?[9):(J6]KNV^=,Y"
MHI/89.3[ U\N6^N?M<:KX0C^(5KJ.CG3)8Q>1>&8K:)KB2$C<,+Y18Y';S=W
M/2O0E447:USY*A@Y5X<_,HJ]M7:[\C[CHKS?1OC)::;\'M-\;^/;=O!+/ IO
M;2_!5H9LE2JC&3N(RHQG!%4OAA^U!\-OC!K3Z1X8\0K=:F%9UM9X)('D Y)0
M.HW8'/%5SQT5]S#ZO5M*2BVEN^GWGJM%>':]^VE\(_#5]J=EJ/B5X+S3KMK*
MXM_L4Q<2*2&P O*@C[PXJ2]_;/\ @[8W^FVLGC*V=[]$DCDBBD>.,-T\Q@N$
M/J&QCO2]I#N7]3Q#U]F_N9[;17%?$SXR^#_A!HUOJGBK6H=-M;EML& 9'F.,
MG8J@EN".0.XJA\,?V@/ GQALKZX\*ZXFH&Q3S+B!HWBFC7^\48 X]\57-&]K
MZF2HU7#VBB^7O;0]$HKQGP9^U[\+_B!XDTK0="UV:^U74G9(+<6,P.5SG<2N
M%'!.3BO%/V=_VX='LO!.I'XL>,/-U]M<G@M MB-R6HCAV%A#& %WF3YCSUYX
MJ'5@FM3JC@,1)2?([JVEG?6_^1]HT5X9\<_BK::=H'@75]'^)0\(Z=K.H1K#
M=VNCKJ::DC $1<_ZL'^_VKH?B=^TS\.?@_K-OI'BCQ"EEJ4R!_LT4,DSHIZ,
M^Q3M!]ZKGBKW9BL-5DH\L6V[Z6?3Y?E\SU*BOD7X&_M ^(/B/+\<KJ]\88T+
M1(Y)='U*.PBD%C#MF(E"*@,NT*IVMG.W'>L/X@?M@77P[^#_ ,.9-,\9IXOU
MC6[N26Z\07.BFT,MBES*DCK !M1E*B/')(7=CFL_;1MS'5_9U=U/9K5Z+KU5
M^W_!/M:BOG\_&W3/&'Q9^&K:!\19K'1?$%E+<0^&SH1<:H%,R[S<, T&#&?E
M[[/]JMSQG^UW\*? 7BJ7P[K'BB.+5(7\N9(8))4A;NKNJE01WYXJ_:1W;.9X
M2M=1C%MM7M9Z:V['LE%>>_$'X_> OAAX=TS6_$'B&"VT_5$$EB\(:9KE" VY
M%0$D8(YZ<BH_A1^T)X#^-<EW%X2UQ=0N;51)-;21/#*J$XW;7 )&>,BJYHWM
M?4S]A5Y/:<KY>]M#T:N5@\"I!\2KCQ=]K8R3::-/^R[. -ZONW9_V<8Q755P
MEKXRU";XTWGA=O*_LN+1A?+A/WGF>:J_>STPQXQ6%=TUR>T756]3CJ.*Y>;O
M^)W=%%%=)J?)'_!3"=H?@=X:0#*R^*;9&/H/LUTW\U%?GGXTNS;>$;PJ?FD5
M8A_P(@'],U^C?_!2'3C=_L[PW0SBPUVSN#CT.^+^<HK\T_'DV[PDA_O31@UX
MN,5Z\/ZZGZ;PY4Y<JQ26^OXI(P+;Y+.%!T"T^HK<YB7Z5+7.>NMD%%%%(85Z
M#X ^/WC[X7Z0^E^&O$#6%@TQN%@EM8+@12E=IDB\U&,;$<$I@FOH#X=_#WPM
MX^_8QTFW\3^,;+P';Q^+)94U2ZLS<>:X@<"' 93R&9LY_@Z5T?QP^"'A[Q]J
M+:#HET=1\3Z/\/M,U#0[JV CAU&**:83$Q\DLZ8*\\'J:Z52DES19XU3&T9R
M=*K"Z3:=U=:==5;K\CYC\,_M&_$?P?I,VG:7XGGAMI9I;C,T$,\L4LN?,>*2
M1&>)FR<E&4G)-<[HWC^_T+PIXCT*VM[7;KQA%Y?NKFZ\N-]_E*V[:$9L%@5)
M)5>>*^H-<_9V^%G@_1?B%=7UKK>JS^"+'31>Q6NH+'Y][, 94#>6P51O1<X.
MW#=<4MA^R;X)U"YO_%%I)?3>%CX9T[7K/1=0U."PEWW;2*L<MY(-B*OE,<[>
M=P ]SV=3:XEC,*DY<MKVZ)7>C7YIZG@/Q5^/GB/XO:7IMAK%OIUK#:327;M8
M0NC75PZHKS2;G;YB$'";5Z_+7FU?6^L? 'X5>#=(^(WB6ZN;WQ1HVAVFEWEE
M9Z1K$#/')=2/$]M+.BNA*NH^8#[O.#D9\2^(/P(\5^"?!>E>.[[1TTWPEKTD
M;:8QO8YY-DL;2Q*P4[L^6IR2HZ=NE1.$MWJ=.'Q%"W)3]U=.FK5[+[SS6BBB
ML3T0KD_&]L)+*7C^&NLKG?&&/L3_ .[6D':2.;$I2HR3['>ZI>_VAX,L;ICN
M:6U1V)[DJ,U^HW_!.R:2?]C;X=M(,,$OD'3[JW]P%Z>P%?D_]K$?PRTAFX_T
M)?Y5^P?[%.@2>&_V4/A=:2 *\FB0WN ,<3YG'XXD%=.!C9S]3P^*JGM(X=O=
MQO\ @CVRBBBO6/S\*_&_X@7!G^,WQ'=QM;_A)-17!]KF0#]!7[(5^//QDLCH
M_P"T)\2+)CR-<N9>?^FC>9_[/7EY@OW2]3[K@^26/DGUC^J/%;BZ^U>)M6N,
MYQ(8U^@ 7^E%4;.3=?7Y[F=__0C5ZN&UM#ZOFYFY=VW^(4444@.W^%GQ>UGX
M2WVI2:=;:?JFGZI;&TU#2=7@,]G=QYR!(@93E3R""".>Q(/8Q?M8^,6\7ZMK
M5Y8:%JECJ5E#ITOAV]LBVF+;PG=#&D0<,HC;)7YLY)SG->HZUXG\%?LQ^%OA
M]I7_  J_P[XXN]>T2VUW5-4UZ%9Y)#,H/EV[,I$:J,@$ @\'&0<]EXY^"'PL
M\ ^"_BJNJV-SIVAVNI:3<6LUE:176J6:3PJQMXWF8%1N;)RWW1W.*ZU"25E+
M8\&>(H2ES3I?%HGWU2_R\SY(\8_&/Q=XW\3ZQKM[K-S:W.JD?:(+"5X(-BH$
M2,(IQM5 % .>.N>:Z;Q+^TOXG\1^"I?#<6F:#H27:VZ:CJ6BZ?\ 9KO4A!GR
MQ.P;;P26^15Y]N*]HTW]A2QE\0Z]<-K&LZUX7MM/L]1TZ'1;.-M3NDN2P161
MV" H$;<<\@9&.E.TO]AW0;7QCXNT75O$>K:E/I<MN]EI6AP0'49;64 ^>\<K
MC*INVMLR<J2.H6E[.K]Y;Q>!=E_+;IZ?EI_2/%OB+^TYXM^)GA.;0M2M-'LU
MO9(9M4O].LS#=:J\2XC:Y?<0VW&?E51FCPS^T!-X5M_#=A9Z'$FDZ5IE[I]Q
M:BX(>[>[5EGN-^T['(*A>& " <BO7/ 7P<\(V_A*>VUE)=0TB'XD6NBF>31U
MM]1EB>%=J,TFV2-"Q4.F1P68#.*?\7_V:O#'C+Q-XQG^'#WT&IZ1XH@TG4=&
MEMXH[>VCG8QB2W6/DQJY4?-CC<3C')RU/BOJ)5L(G[)QM'\.B_6WD?.7Q8^(
MMS\5_B!JWBFZM(K"6_=,6T+%EC1$5%&X\L=JC)[G/ Z5R5?2?Q!^&/A/X3^
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MMMCYR\2?'[QKXML?%%GJFJ)<VWB,6JWT?D(HV6[;H4C '[M5/\*X%>=U]?\
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ME%\6:QI.IQ(;A<VZV<ZRLC?+\Q8# (QBI_==#9/'MWE^G=?I?[OO?JO[*?\
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MB^6Y]G?\$_/@ ?@S\%H-6U6%D\5^*BNI7XD&&@C(_<08[;4.X_[3MZ"OJ"D
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MCVJLU"#DS<^"MJ\M[KE^>(RR0J?4C)/\Q^==+XZUW[+:^1"&DGD.Q$099F/
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M#^^<']VG7Y%^8]RN,']*M#T+3O#.DVFEZ186VF:;:1B*WM+2)8HHD P%55
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M%%%=)J%%%% !1110 5X]\5?V4?AU\6_M<^IZ,MCJ=P#NO[#$3EO[S+]US_O
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M%^S/\.?@?;*OA7PW;6UX!AM1N1YUTW_;1N1]%P/:O4:**U//W"BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M<:DHVT3MMV5WU0G6:DUY_I=GU%17RY/\?O%'BWP+\-=#\+:A&/'GB1%:\O\
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M8[E/E(H3.T@=.=OJ<UT/PF^*7B Z5XD\0:IX[T?Q[X9TVS:XS;6GV._B<#<
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HI"0H))P!R37%>&_BWHGBF6Q%I%?P
M0WU]>:9!/>VK6X:YM\EHRCX<%U25T)7!6)CD94, =M117GOQ7^-.F?"1],2_
MTN_U22^2>55LIK2+RXX@I=F-S/"#]]<*A9CSA30!Z%17+V?Q/\*7VI'38_$&
MGC4U2)WL7N%6>/S-NP,F<@G>@QZL/45/X=^(7AGQ?=M:Z)KVGZM<+ ER8[.X
M64B)@"K\'[I#*0?<>M '0T5P?B'XU^%O"^M:EI.H7GDZE8R641MB\8DF-TX2
M,QJ7!8 GYN. #UJVGQD\"R1[U\7Z,4\QXMWVV/&Y5W,.O9?F/MS0!V-%<!=?
M'?P/:30;]?LS9S6LMTFH"=/LY"2)&T>_=]_+CY<= :Z.V\9Z3-X/M_$\]W'8
M:--:I>?:+MU18XV (+'.!U'>@#<HKF/#'Q)\.>,]7OM.T35(-2GL[>"ZD:W<
M.ACFW^600>?]6U4]=^+WA70M4&F/JL%WJHO;6QDL+25'GB>>>.%&=,@A0TJ;
MCV!Z'I0!V=%8'BCQC!X7>UA-A?:K>7*32QVFFQ+)*4B3<S[2PXW&-./XI4[9
M(XO2/V@M,U;5+33CX<UZTNO/%KJ2S+:LND2-,T,2W#).RMYDB.J^09<;3OV8
MH ]3HKS/4/C[H=EHMAK$6E:U>:9<ZJ^E/<I:K"+9EF$)E=9G1BA8@JJ!I''*
M(U;FH?$_3;'PM+K$=G?7LR7C::FDVR(;R6\$IB\A59PF[<"=Q<(%^<L$^:@#
ML**\TTOX_P#AFX\1:9X?U9+OPOKU\LX&GZT88WCECDA0PEDD=&=OM$3+Y;.K
M _>SQ6XOQ>\$O]WQ7I#'[5]BPMVA/G_\\^O6@#KZ*X/0OC?X.U[4=0T]-9M;
M6]L(DFN8;BXB^164/]Y796PK(202!O'.<@=-XE\6:+X-TPZCKNJ6FDV 8)]H
MO)1&FX]!D]^#0!K45Y]K/QW\&Z1K$6F#6+6]NF>)91;W< 6W$DL42F1GD4#F
M=" ,LPR%#,0IT;?XP^!KN&UEA\6Z/+'=3FV@9;Q")) %)4<\GYT_[Z'J* .P
MKYSLOV<O$UKX#^)6GG4]+_M[Q?>K*+E6D\J&#S-S(3LW9(+C &.1S7I.O_'S
MP/X?LK>]EUVTN;&6_336NK6XB=(IVECB"L-X)PTJY*@[1DG KL=*\2:5KLDL
M>G:C:WSQ1I*ZV\JN55]VPG'0'8V/]TUA5H0K6Y^E_P =#.=.,]SY,^+O@&34
M/&/P>^%-E>?8Y-.T\R/<VZ;@DH4$R@'&>8BW..IKTWPK\!O%>I?$?3?%_P 1
M/$]KX@N-&3;IMK90&.-6[2-D#!SSP#DXYXKO[[XD?#JSU&^O[O7_  _'?Z5(
M+2YNI)XO-MG)91&S=5)*N,>H8=C5O3_BMX6UGQ-9:#IFL6NJ:A=6[72K93)*
M$B"*X9L'@,KJ0><YKEA@H*;G+75>FB5O6QDJ$>9R?]6V/,_!W[.%Y:^$OB-I
M?B'4+66]\6W+R_:;$,WDKRR9W $X8YQT.*XS6/V7_B9XD\#Z7X4U7QSIUUHN
MFSQ+!:+$Z@P("!N?;DLHP%4\#GG@5[OI_P 9_!NIZ_J6DVVOV,D^GVZW$\HN
M$\H F7<N[=]Y1 [,,<#!]<5-9^.O@_2VT];?4X=7:\U8Z+_H$\++!<B&>8K*
MSNJK@6T@ZYW8&.:J6!HRBHM/MN^]]?F-X>#5CNX+2*UM([:%!%#&@C1%Z*H&
M !]!7RNO[)OC/3M&\5Z-IWB+05L-8F>87<]DS7KAB/W;2X)1< YVYSD^IKW8
M_&OP0\ N8/$VE7-BLABGNXK^'R[<A"XWY<'D#C:"?PR0ND_&GP5J]I:3KXBL
M+;[7'-/!%<W,:/)%$\BM(!N^Y^ZD(/HI/8XVK8>G7MS]/U+G2C4M<\[E_9XU
M2YU+X2"2]L%TOP;:H+J!6?,]P I=X_EQ@L@/.#711?"#4I_VAY?B#>7=I)IL
M6GBSM+52QF0XP6/&.[]#WKI++XS>"]74_P!E>)-+U9U9 Z6E]"2BM((]QW.!
M@,<'OV )(%;7AKQOX?\ &-HEUH6LV6KV[LR++9S+(I90I89'<!E/_ AZU*PM
M)=.J?W*R$J45^?W'@@_9N\>^'=1\6VOA7QM9Z9X<U^66>2&6!C.K,#\H.#CK
M@L#G':O5/@/\,IOA)\-K#P]=SPW5[')+-<36^?+9F<D8R ?N[1R.U;GAKXA:
M5XJ\0>(-(LA.+C1I5BEEEC"Q3Y!!:)LG<%=9(VZ$/&PQC!-6'XP^!KAK=8O%
MVC2-<SFVA"WL9,D@VY5>>3\Z?]]+ZBBGA:=*7/'?U[A"C&#NCE1\(=4N/V@[
MCX@W-W9O8Q:;]BL;8%S+&VW!9OEQC)?H>]1?!3X*7WP^\,^*[+7+VUO;_7[R
M6::6TW% CI@ [@"3EG_.NL'QH\!D7./%^C-]FF6WF"WJ$QR,7"J1G@DQR ?[
MC>AIVH?&/P+I0NS>>+M'MA:3_9I_-O$7RY<,=AYZXC<X_P!AO0TUAJ:ESVUU
M?W[C5**=_7\3SG]G']FQ_@Y=ZCJFLWEMJFL3#[/:R0%BEM;YR57<!@L>N/3W
M--\5_ OQEIOQ'UGQ9\/?%%GHTNN1A;^WU& N P_B0@-]>0,'//->K6OQ&\+7
MNI2:?;^(-.FO8VB5H([E2P,@!C&,]6#+CUR*DT?Q[X;\0:I+INF:Y8:A?Q1"
M9[>VG5W5" 0Q /0AE/XBI6$I*FJ<59+5:Z_>3[&"BHKH>5?$7X%^*OB!X0\'
M:)J7B>#5I-.U$7^J75U&8OM ' 6-$4CA6<?,>_OQ[FJA5"CH!@5P4_QW\!P:
MK8V'_"3:?))=BY*RQSJ8D^SH'EW-G PK _GZ&F6_Q]^']UJ%[:IXIT[;:6D%
MY)<FX7R2DLLL2A7S@D/ X([<>M;0I1IMRCN[?@:1@HMM&7=_"75-2_:'L?']
MW>VK:5IVFFSM+12WG*[!@S'C;C]X_?/2O/-0_9C\76OBOQG?:+K^B"T\1/+(
M;G4;)I;V#?N)1'P=H^;&X'ISBO9G^,W@2/48K!O%^BB]E>.-(/ML>YFD(" #
M/)8LH'^\/44V[^-/@*PMY;BY\8Z+!!%.;9Y)+Z,*)=K,4SGKM5C]%)[5C/"4
MI[][[]69NC"6_J>2:K^S#K>H?L\Z5X BU>PMM3L[TW<EP Y@FY<[2<;A]X<X
M_AKW'P-IVL:1X3TVSU^[MKW5H8]D\UG'Y<1P> JX& !@=.U<SKWQU\,:)X9U
M36XY)M3AT_6!H+P6C1+))>F58O*4RNB##M@EF4<'VSJVOQ@\#WK0"#Q;H\IG
MMWNXME[&=\*;]T@YY4>7)S_L-Z&KIX>G2ES0[)?);%1IQ@[KT/+M6^ ?C71_
MB7XB\0^"/&%MHFG^(CYE_#<P&25'YR8^",Y+$'C&[OBL&S_98\26'P*U+P5%
MJ^F-K&IZJ+Z[O7:0QM& ,+G9N)RHZC')KWCPU\3?"7C*2:/0O$>F:O)!$9I4
ML[I)"B!BI8@'@!@1]17*^!_VE?AYX_MI9]/\06UM&D*W*_;I4A,D)@68R*"V
M=JHW.<8*MZ5B\%1;;UUOU?7>Q#H0?]=RCXS^&?CQ+?1H_ _BZUTFULK)+.;2
MM0M5DM9=J[=P^4GD=01BL7X6?LRCPQ9>+YO$NH6UYJ?B:!K6Y328!;V\$9Z^
M6H &<\]!TZ=:]!\3?&/PSX9\*:;XE:[;4]$O[Z&PCN], G16>0H7;!^XA#%R
M,D!3P<57M/CKX)F@N)+K7+;3&ANKRU\F]E1))#;2R12NB@DLI:)BIZD=L\5H
M\+2<^=Z_-V[;%>QA?F9X['^S!\09O#</@:Z\?6A\!13;O+BM2+IX]^[8<\#G
MG&X@'L:[V;X$2CXO>"=?MI;2+POX6TPV5M8,S&8R;9 '^[MQ\R=^JYKIO"_Q
MR\&^*M-T:\AUJTLQK(C-A!=W4(EN-Z1N %5VY_>H-IP<D<<@FS%\:O ,]L+B
M/QCHKP&<6WF+>QE?-P&VYSUP0?Q%1'!T8[+MUOMLO02H07]=CD?C9\%M<\=>
M*?#?BOPKKEOHOB'10R1F[C+1.A.>P/(R>,'.>V*S/AG\!_$V@?%K4_&OBWQ#
M:Z_<W5B;9'A1D96.T$;<850 0,&O0M*^+&C:Q;^')H(KL)KNL7FB6N^-05GM
MENVD+_-PA%C-@C).4R!DX)_C#X3M;Z\T^?6K&'5[83,=->]@$[K'OR0/,P ?
M+?&XKC:<XP<6\+2=3VG6]]]+^@W2BY<QY)X>_9^^)'P_DNM%\(>/+/2_"4UX
M;I%FM/,NH0<949!!X&/O#..U=GJGP<U;6/CGX;\9W>I6]SI6C:?]G6*3(N))
MMK O@+M );/!_"NP\._%'PYXL\1S:)I.H17U_;VOVJX6WE218!N"[&*L<-D]
M!D<'FJ&D_&WPCJFFW=_+JB:5:0:F^E++J1$"W$J[MK1$GYT<(S(P^\H)'%*.
M$IQ7*KVNGN^@E1@E9&/\4/ _Q#UK6H[_ ,'>,+73K1X?*N-(U6U66V?L6!"D
M\CJI'X\XJC\ O@3<?":XUW5=4U&VOM:UF0-,FGP""VA4$D*BX'<GL/3%=I=_
M%KP78+?M<^*-*@%A.+6Z+W2#R93NPC<\-\C\?[)]*BO/C!X0M;TVBZ_IUS/'
M.L%PD5] #;Y1GW/N<<80\+EO; )%_5X>T]J[W]65[*/-S]3LJ*\\C^/G@B\U
MRUTJPUVTU&XN(!<J]O<Q>6(_.$))=G R'/(&3QTZ Z,/QE\"3PZ7+'XOT9X]
M4F-O9,+V/%Q(&1"B<\G=+&,>KKZBNDU.RHHKBK#XR>$;NXFMI]:M=-NX[F[M
MOLM_,D4K&VFDBD<+N^YNB<@]P.@Y% ':T5RNH?%3P=I./MOB?2K7*N_[V[1?
ME2))G/7H(Y(W/HKJ>XK/U+XX^!M.TI;]?$VFWBRVMQ=VT-K=1O+=)")/,$2[
MAN8&*1<>JD=C0!W5%<[??$/PWI4^F6^HZS9:==ZE#Y]K:W4ZI+*F <A2>>M<
MQ8_''3];\$^'_$6AZ!K6O-KR/-8:78_9?M4L*\M*2\ZQ*H&#@R!OF QN^6@#
MTFBO.H/CUX2%]J5MJ5VWA\:>L/GR:RT=KM:6&*5$V,^_=MG4'*@!@PSTSKVO
MQ9\)75]:VG]OZ='/>N$L5:]A/VP&-) T05R2"LB=<'D<8() .NHKD=%^*WAC
MQ-J,5IHFJ0:R)(9YOM%A*DL2>5Y>]&8'AL31D#T.?3,;?%GP[;Z-H6K7UXFE
MZ;K%B=0AN+^>&$1QXB(#@ONR?.0?*& /4C*Y .RHKSK6_C_X)T'1+S59]:M9
M;.$ P&WNH9&O28Q)B%0^2<,.&VG\"";M[\:?!MGJ<-D-=L[B1KB:VGD@G1DL
MVC@FG<S'=\BA8)!GGD8]< '<45QLOQF\"006LTGB_1DBN4:2%VO8P)%4E6(Y
M[%2/J#73V.JV>IK.UG<Q78@<Q2>2X;:X .TXZ'!!_$4 6Z*\Z\/?&>WUG5;S
M3K[PSK?AZZM;S[&PU)[-T;$)FDD#P7$JA$3:6W$$&1!C)Q4_@[XV>'/&L=K+
M:?;+.VNYKR"UGOX/)6=K:X\B3;DY&X[70, 61L@<,% .^HKRJX_:$TV*^UG3
MH?#'B*[UG3;E(!I<4-NL]U&RRL)H]\ZH%VV\K;9&23"J=F'3=TOAOXJ^'O%W
MB:30](N);RYCTZ'4WF2(^2L<OW$+G_EI@JQ3JJNA.-PR =A17G?C+XVZ7X&\
M176DZCH^L-Y.GS7\=W#%"8KDQIO:&,&4/NQ_&R"('Y3(&XJMH/QZTK7M5\-V
M*:'K=L=<WI'<SQ0&W@E7SOW+2)*RRMBWD),'FJHV%V42(6 /3:*** "BBB@
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M&"&Y2)VMXXEB\M1N0K)AXO,_>*V2Q!!7"UX#>_L$BYT62TC\0^'(YY;*QMI
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M^R!=7GB2XDFUC3(K"+2XK&*^;2!)?W+_ &>2.56E\T!+5WE+26VT^9A1O7%
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M P<J2WH/CSX;?\)OJ+77]H_8L^']5T+9Y'F?\?AMCYN=P^Y]F^[_ !;^HQR
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MX3?#KQC:1Z1I>MZ^NGQ/-=6.DRF2W2UR&$SQK+$&<,UR6)<N 7PN%RM;6J_
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MZ/X*NCHTFEZQXJ5!']IO-,1!?P!(U^QW'[S,EN6CW-"7"N"4RF[> #TGX=?
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MY?/4;;/A3]GJW\ WVNZCH5W96]_K=O<1:E+#8>1+>%YII8V:57SO3SMBNP?
M!P.<  ]>@C:&".-I7F95"F23&YR!U. !D^P K/\ $/B;2_"EBEYJ][%86SR+
M"LDIX+G.%^O!_*OEKX;?LA^($T8R:^_A?0KS^V3>QV5GH0EAM8?LUG%YMHHN
M,6MV7M9&\\-)GS6;8I<HOH-]^RU'<Z/J^EQ^(4_L^Z6:*TMI]/\ ,CM(OD6U
MAP)5W1P1FYC"\96<?=*98 ]XJHVJVB:I'IIG07TD+7"P?Q&-656;Z LH_&O
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MO--<SW&S9YDDDC.V%). "V ,G  &>*UZ "BBB@ HHHH **** "BBB@ HHHH
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M5GW7QE^)EU/]DTSPY;BYFU&2!GNM$O?+TZ-;>]D\N0^8HG;=;0+YT;+&3.
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M2N]QY^^)I?NL5R-F[: #T?X1V_Q$T.QU*+QO=:KXBGCN$-G.ZZ;&98GM+-I
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MO<33KJ>IR?:=/T2+;' 9HXE,7V@L @\R5P[ $J@PF-@)-8_@/PE\0K;]GO\
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MB1T^\4'F&.[0Y=A@39) )KH],\;>!/$-Z_DWFD2ZE!)MEB8Q--#+RY!(SR#
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MW.FRWR1^3'^\6".5U&,DD%A$,XX)'3BJ&H>/?AOJ5K8Z5K=QHD;QW,<*:3J
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M>2!D.,_+S5U[]K"31YM"G;PG=0Z;>%[J=WF265K/[)>S(T2(23(6LR-G)QP
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-QT/$7[,4'B;X/:7X%N]5L"MB]U,)?[(!M&DE:1U MC+\J(\@(7>3A -P/(
M.U\2_!3PUXKO]0O+Y+K[1?7'VJ1XIMNV3[+]E#+QQB/D?[0!JO8_ KP]90WP
M:YU.YN[Z2*>ZOI+K;/++')-(LFY NUMT[_= P N,8KF_ 7[/$W@JQ^(4*ZMI
M,3^*P^/[)T>2UC@9A("\@>YE:5OWG9HQ@8 &<CA/"O[%=QX7N="EC\1: _\
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MQ!%BF$X0!;.#YE(;(.",XKJ+/X Q6OP:UOP$=9WG4[$6)OOLF$A41+& D._
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M&T@@"_!(?$VUU73K_P"(&FZU<7,]J^G&>\33TEC/FO*LDZ6<[PX"C:'0 G*
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MT]G<Z&@T\$J8K,*T19Q&P0!,[BS!2%YY&1S0!%\(?CU:?%#6-5TB33Y]+O\
M38H)&-S%)&MP) </&2OEL#C.$DD*Y ;:P*C%\4_M2:?X;^)VH>"(_#U_?:E
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MT#[6)RX&.N0+B_%/X;WT-F/[7TJ5+N>2*!&C^^[[1(=I7@-YR98\'S5Y.X9
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M2H5P[%PQPD+_ "$D =-J/Q9^%-@\%W=ZQHBR.!?QS-$&8-LQOSMRKA(2".&
MB;/W#B[XB^,7A'PK=V]G>OMNI=7M]-M88XT+333S00^:G/"*]TH9C@\/@,<9
M .2UGXM>)H=3T.*QU'P\DNI:S<6<.D7%A,US<6]O.()F\W[0J0 &.>3S'##Y
MXH@CR8\S<C^)GB"SFU)M2L=-C2S\1KHWV>W=V)BDMH9(7,K8 8/,-_R[0N<?
M=RT,7C/X:27MW=V,-KK4[37%_(RA96BF180QB25@4WY0CRAL9]S$[F):+Q?\
M5?"T)>[D\-:WK=]I>JR6B6%K;K%)+,+1I)9@DTL:2(D ?YFSG&(PQ*Y ,'Q9
M\:O$VF^,-7TO2]6\+S6<,]K9/--93%-'EGFAC1IY?M"K<G:[L8XUCV'RPT@W
MKGF=/_:(\6>(?%-II=[9^%[71)H&MC=WJ,5:\6R:\2] ,W%IF,IR#\P'[W/%
M>S:KK'@W3KW0VDT>"Y;Q4'CBNX=.5TDC$)F)F?'"E$X#<DXP.#CBXOCWX8E>
M,_\ "!:T+T6GF" VMCYBZ.0"+W(N-OV4DX\L-YN0?W/% &99_'@W/@"74M:E
ML=%\8::+E7UB?PS>W>FQ(MSY1$;0.\;S2*(\6T5T[LQP"VVET+XQ>.=6U1;&
M]O/"^BW0C^RR6S63W4J3?81=F^_=WFTV^6\KRE8X96Q.U=)>_%GPO8:+XDL-
M3\%ZE8:7H2I*ME<V=J8[V%GEVRP1K*0JDPR,%E$;XPVW!!K4T/XF_#2]LM'U
M&SO-+MOMZ_8;7-N$D4#9F$X7Y5!FCSGY<R+S\PR <II'Q/\ &\>K>!-.U+6/
M"MWJ.KQ?;;[3K;2Y[63[&TAVSAY+ME@*QE/D(F:5]P4*JLZ='\9_C._PT.EV
M=A80WU_J-O+=1RW-PD4"11S6T3=6!D<FZ0A%/(5CG@!MBS\4>"O&%O>ZOI%O
M9^)[O28LJMG;))<8 ;:L18#[Q#!2"%SGD8-<C;?'KPSK_B+PWX=U'P=JMKJ-
MW=2VZV^H16,@T^>)MA!*7#B0YZFV\WRQ_K/+H ?H/[0\7B7Q1#H]KI@MI'#S
M+YLZ.)(MET4WL&'V=]UJ^Y75L COG;N_%GXC:U\/M4\-_8-+MM2TZ^:^6X0N
MWVEVAT^YNHXXE P"S6X!8YZX"\Y&#=?''P58:-+K-EX;N[_29]:.E7-]:6MK
M'&TC!%,Y\R5#*C"4!1&'DD&=B,.O57/Q:\-QR:L]U%<P_P!B:E'I[RW5MY>9
M'C#-)%OP618W=F<?PHY&X#D H?#7QSKWB;0-8CN;WP_K^MVD@6UN]*5[6QNM
MT,<@X,D[ (9 K,&;L<#.*\_LOV@_%5W)HDIAT"/[3H]O<S:9(&CGFGET^XN_
M/CE>8*ENCP",[U/\9,B[<'U;0_&G@:*V0Z9=Z=9Q1QK*J1P^042:1D4[2H(#
MO"PZ<E/:LRW^+?PQNH['48=:T>029L[>X6,95-J,5!VY6/;+&V3A<.IS@@T
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M0KO);Q,2<\@XQN;,<'[/7@^#P[<:*8;R6TGE,[O+=,TID-LMOOW]=P1%(/\
M>&>M%% %"]_9C\&:GK.F:O>I=7NJZ=%=QPWUSY,DY-R)1.YD:,M\XF<%00A
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
&**** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>alt-20251106x424b5009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 alt-20251106x424b5009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "Y 2,# 2(  A$! Q$!_\0
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M^8TO:X>5U^*]26BDZTM<9Z(4444 %%%% !1110 4444 %%%% !1110 4444
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M]@N6\76$WM 6D/Y!37 >*?V\? VF1NFDV>I:U,/NLL0@C/\ P)SG]*\NMOV
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MZ[>VW@>UUR]&J"8V_EL4BN2PZJTIYXKKF_8W^+/B8F]U77;0W+\D7>IS2O\
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#G__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
